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CHAPTER 1 INTRODUCTION 
 Regulatory factors such as transcriptional activators or repressors and 
chromatin modifiers identify their target sequences in the chromatin with high 
fidelity, ensuring appropriate gene regulation. Misregulation of gene expression 
can be catastrophic leading to birth defects, developmental abnormalities and 
cancer. How the fidelity of regulatory factors for their target chromatin is 
maintained is thus a very important aspect of gene regulation, but it remains 
insufficiently understood.  A particularly useful, genetically tractable model 
system to study this aspect of gene regulation is the dosage compensated X 
chromosome in Drosophila melanogaster males. In fruit fly dosage 
compensation, all the genes on the single male X chromosome are upregulated 
approximately twofold, via chromatin modifications, to equalize gene dosage with 
the two X chromosomes of females.  Thus this process calls for highly selective 
identification of the X chromosome in the nucleus by the dosage compensating 
machinery.  
Dosage compensation in Drosophila melanogaster 
 The MSL (Male Specific Lethal) complex brings about dosage 
compensation in Drosophila melanogaster (GELBART and KURODA, 2009).  
The MSL complex is composed of five proteins MSL1, -2 and -3 (Male-Specific 
Lethal1, -2 and -3), MLE (Maleless) and MOF (Males absent On the First); and 
one of two functionally redundant long non-coding roX (RNA on the X) RNAs, 
roX1 and roX2 (reviewed by GELBART and KURODA, 2009). MOF is a histone 
acetyl transferase responsible for the deposition of the activating H4K16 
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acetylation mark (SMITH et. al., 2000; AKHTAR and BECKER, 2000). CLAMP 
(Chromatin-Linked Adaptor for MSL Proteins) is a recently identified protein 
crucial for recruitment of the MSL complex. CLAMP tethers the MSL complex to 
the X chromosome by directly binding to specific DNA motifs  (SORUCO et. al., 
2013). Other trans-acting factors associated with the MSL complex are JIL-1 
kinase, which brings about H3S10 phosphorylation, another histone mark 
associated with increased gene transcription (JIN et. al., 2000; WANG et.al., 
2001). The NSL1 (Non-Specific Lethal 1) complex is a non-sex specific 
transcriptional regulator in fruit flies, and it shares the MOF subunit with the MSL 
complex (RAJA et. al., 2010). It is enriched at MSL-complex binding sites on the 
X chromosome and is involved in recruitment of the MSL complex (LARSCHAN 
et. al., 2012). In addition, DNA Supercoiling factor (SCF) and Topoisomerase II 
are also enriched on the male X chromosome and required for proper dosage 
compensation in Drosophila melanogaster (FURUHASHI et. al., 2006; CUGUSI 
et. al., 2013). Thus the long non-coding roX RNAs and several protein factors 
cooperate to bring about upregulation of the male X chromosome in a highly 
regulated fashion. 
 Various models have been proposed to explain how the MSL complex 
modulates RNA polymerase II (RNA pol II) activity to bring about 
hypertranscription of X-linked genes. The transcription elongation model states 
that H4K16ac leads to a reduction in torsional resistance for RNA pol II during 
transcription, leading to increased expression (LARSCHAN et. al., 2011). The 
discovery of a statistically significant enrichment of stalled RNA pol II at the 
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promoters of X-linked genes led to the controversial promoter proximal RNA pol 
II enrichment model, based solely on increased initiation of transcription 
(CONRAD et. al., 2012; VAQUERIZAS et. al., 2013). The “Jump start and gain” 
model is based on an increased rate of release of RNA Pol II from its paused 
state at the promoters of X-linked genes, and an H4K16ac-dependent decrease 
in early termination of transcription (FERRARI et. al., 2013). The exact 
mechanism, however, remains elusive and could be a combination of several 
different factors (reviewed in VENSKO and STONE, 2015). 
Selective identification of the X chromosome 
 Appropriate execution of fruit fly dosage compensation entails highly 
selective identification of the X chromosome in the interphase nucleus, and this is 
a multistep process. The MSL complex is thought to initially assemble at sites of 
roX transcription (KELLEY et. al., 1999; BAI et. al., 2004). This is followed by 
recruitment to ~ 150 CLAMP-bound Chromatin Entry Sites (CESs). CESs contain 
a 21bp, GA-rich motif called the MSL Recognition Element (MRE) that is bound 
by the CLAMP protein (ALEKSEYENKO et. al., 2008; SORUCO et. al., 2013). 
From the CESs, the MSL complex spreads in a sequence independent fashion to 
actively transcribed genes in the vicinity (ALEKSEYENKO et. al., 2006). This 
spreading depends on the chromo-domain of the MSL3 protein, which binds to 
the co-transcriptional H3K36me3 mark associated with gene bodies of active 
genes (LARSCHAN et. al., 2007; SURAL et. al., 2008).  
 Although these crucial findings over the years have helped to elucidate 
how the recruitment and spreading of the MSL complex take place, the 
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mechanism by which it targets the X chromosome with exceptional specificity 
remains unknown. MREs are present on all chromosomes and are only modestly 
enriched on the X chromosome (ALEKSEYENKO et. al., 2008). In addition, 
besides being essential in both sexes, CLAMP also binds autosomal MREs 
(SORUCO et. al., 2013). These findings rule out the MRE motif and CLAMP 
binding as factors that specify X-identity. 
 In mammalian dosage compensation, expression of the long non-coding 
Xist (X-inactive specific transcript) transcript marks the X chromosome for 
inactivation (BROWN et. al., 1991; BROCKDORF et. al., 1991). The location of 
both roX genes on the X chromosome in fruit flies suggests a similar role in 
marking the X for compensation. However, roX RNA transcribed from an 
autosomal roX transgene can restore dosage compensation to the X 
chromosome, when both endogenous roX genes are mutated (MELLER and 
RATTNER, 2002). It has been proposed that MSL complexes assembled at 
distant autosomal loci or within the nucleoplasm can travel through the 
nucleoplasm to dosage compensate genes on the X chromosome in trans (PARK 
et. al., 2002). The roX loci thus do not confer X-identity. How the MSL complex is 
limited to the X-chromosome therefore remains a mystery. 
Additional pathways modulating X-identification 
 Our lab discovered a genetic interaction between components of the 
siRNA pathway and dosage compensation in fruit flies (MENON and MELLER, 
2009). Although without a distinct, male-limited phenotype in otherwise wild type 
males, mutations in certain siRNA pathway proteins elevated mislocalization of 
		
5	
the MSL complex on polytene chromosomes and increased male lethality in a 
sensitized, partial loss of function roX1roX2 genetic background (MENON and 
MELLER, 2009). This suggested a role for the siRNA pathway in X chromosome 
recognition and led to a search for the source of the siRNA. A strong candidate 
was a family of satellite repeats with near-exclusive distribution on the X 
chromosome. While related repeats are also present in euchromatin and 
heterochromatin on chromosomes 2 and 3, the X-linked satellites cluster within 
multiple branches of a phylogenetic maximum likelihood tree (KUHN et. al., 
2012). We have designated the X-linked satellite repeat families together as 
1.688X. These X-linked satellite repeats, which band in CsCl gradients at 
1.688g/cm3, had been identified previously and were speculated to play a role in 
dosage compensation (WARING and POLLACK, 1987; DIBARTOLOMIES et. al., 
1992). Our lab showed that ectopic expression of double-stranded hairpin RNA 
(hpRNA) from a repeat cluster at cytological position 3F (1.6883F) partially 
restored MSL complex localization to the X chromosome and enhanced the 
survival of roX1roX2 mutant males (MENON et. al., 2014). These findings led to 
the hypothesis that the 1.688X satellite repeats confer X-identity, thus contributing 
to X-recognition in dosage compensation. The widespread distribution of 1.688X 
repeats on the X chromosome precluded deletion studies. Instead, we devised 
an alternative way of testing their functionality as cis-regulatory sequences.  
Functional investigations of 1.688X repeat clusters 
 The objective of my dissertation is to determine if 1.688X repeats do 
indeed act in cis to direct dosage compensation to nearby chromatin. I designed 
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a functional test that detects compensation of autosomal chromatin. This 
required generation of large, lethal autosomal deficiencies. Recruitment of 
compensation to the intact homolog would rescue males, but not females. I used 
FLP-FRT mediated recombination to generate translocations of large fragments 
of DNA between the 2nd and Y chromosomes. These translocations are 
maintained over an msl-1 mutation, thus eliminating the need for selection. The 
two halves of the translocation can be separated meiotically to generate a 
duplication and a deficiency. Generation and maintenance of such large, lethal 
deficiencies is technically challenging, and the methodology for this is described 
in Chapter 2 (JOSHI et. al., 2014).   
 Next I generated a transgene carrying roX1 and 1.6883F, and integrated it 
on chromosome 2L. This transgene was constructed with LoxP and FRT sites, 
enabling removal of 1.6883F and roX1, respectively, from the transgene; such 
that the role of each element could be tested individually. I discovered that all 
transgenes, including 1.6883F only, recruited the MSL complex near the 2L 
insertion site and increased the expression of nearby genes. When placed 
opposite the lethal deficiency, the transgenes partially rescued male flies to the 
pharate stage. Females do not assemble the MSL complex, and were not 
rescued by the presence of these transgenes. Additionally, all transgenes led to 
a dramatic increase in recovery of male third instar larvae, which was further 
enhanced by expression of 1.6883F hpRNA. My findings strongly suggest that the 
1.688X repeats act in cis to facilitate X-identification and dosage compensation. 
These results are included in Chapter 3, a manuscript in preparation. They also 
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suggest that 1.688X repeats on the X are the targets of the siRNA pathway that 
contributes to X-recognition. 
 The 1.6883F repeat cluster shares 95% homology to 1.6884A. Indeed, 
1.6884A is the only repeat cluster with >90% identity to 1.6883F. 1.6883F and 
1.6884A flank the roX1 gene. This prompted us to ask if these two clusters share 
a redundant function in generation of the siRNA that promotes X chromosome 
recognition. To test this idea, I worked with an undergraduate honors student, 
L.Spencer, to delete 1.6884A. This was accomplished in flies that lacked 1.6883F, 
using the CRISPR/Cas9 system. Flies deleted for both repeat clusters did not 
show an apparent defect in male survival, and survival of females forced to 
inappropriately dosage compensate was not enhanced. Therefore the 
specialized role of 1.6883F, and whether it is unique from other 1.688X repeats, 
remains ambiguous. This study comprises Chapter 4. 
 In chapter 5 I summarize my findings, and discuss the scientific questions 
raised and perspectives for future studies.   							
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CHAPTER 2 A STRATEGY FOR GENERATION AND BALANCING OF 
AUTOSOME: Y CHROMOSOME TRANSLOCATIONS 
 
 This chapter has been published as: A strategy for generation and 
balancing of autosome: Y chromosome translocations, JOSHI S.S., CHEONG H. 
and MELLER V.H., Fly (AUSTIN). 2014; 8(1): 58-62 
ABSTRACT 
 We describe a method for generation and maintenance of translocations 
that move large autosomal segments onto the Y chromosome. Using this 
strategy we produced (2;Y) translocations that relocate between 1.5 and 4.8 Mb 
of the 2nd chromosome. All translocations were easily balanced over a male-
specific lethal 1 (msl-1) mutant chromosome. Both halves of the translocation 
carry visible markers, as well as P-element ends that enable molecular 
confirmation. Halves of these translocations can be separated to produce 
offspring with duplications and with lethal second chromosome deficiencies. 
Such large deficiencies are otherwise tedious to generate and maintain. 
INTRODUCTION 
 Translocations are traditionally generated by randomly induced 
chromosome breakage. Use of the site-specific FLIP recombinase  (FLP), which 
recombines FLP recombination target (FRT) sites, was pioneered by Golic and 
Lindquist, and has been widely used for generation of deficiencies with defined 
end points (GOLIC and LINDQUIST, 1989; RYDER et. al., 2004; RYDER et. al., 
2007). This method also enables recombination between non-homologous 
chromosomes, but at a lower efficiency (BEUMER et. al., 1998). Translocations 
that move autosomal material onto the sex chromosomes allow predictable 
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transmission of material now linked to the X or Y chromosome, making these 
particularly useful. We obtained insertions of FRT in G9a, situated at 1A1 on the 
tip of the X chromosome, for the purpose of generating X;A translocations. 
However, one of these insertions segregates with the Y chromosome, and in fact 
is inserted in a duplication of the X on the Y chromosome (Dp(1;Y)y+). The 
duplicated region comprises 1A1–1B, and includes y+. Using this Y-linked FRT 
site as one endpoint, we generated large translocations between the Y and 2nd 
chromosomes with an efficiency similar to that for production of autosome to X 
translocations (BEUMER et. al., 1998). Both halves of these translocations carry 
visible markers, enabling maintenance by selection. Full translocations were 
easily balanced over the male-specific lethal 1(msl-1) mutation for maintenance 
without selection. 
MATERIALS AND METHODS 
 Flies were maintained at 25°C on standard cornmeal agar food. All fly 
strains used in this study are presented in Table 2.1. Matings to generate 
translocations were set with 5 males and approximately 20 yw females per vial. A 
generalized overview of the mating scheme used to produce T (2:Y) is presented 
in Fig. 2.1. Primers for molecular characterization are presented in Table 2.2.  
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Description Stock #, 
supplier 
Genotype Flybase Id # 
P{RS5} on Y 43649 
(BDSC) 
125639 
(DGRC) 
Dp(1;Y)y[+],P{w[+mW.Scer\FR
T.hs] = RS5} G9a[5-HA-2731] 
y[+]/w[1118] 
FBab0010476; 
FBti0059095 
P{RS3} at 22A2 124255 
(DGRC) 
w[1118];P{RS3}CG18131 
[CB6892–3] 
FBti0059228 
P{RS3} at 25B1 124291 
(DGRC) 
w[1118];P{RS3}CG3036 [UM-
8026–3] 
FBti0029115 
P{RS3} at 56C6 124216 
(DGRC) 
w[1118]; P{RS3}CB-6775–3 FBti0058933 
P{RS3} at 57B1 123609 
(DGRC) 
w[1118]; P{RS3}CB-5407–3 FBti0028557 
3rd chr FLP 8705 
(BDSC) 
w[*]; wg[Sp-1]/CyO; P{w[+mC] 
= ovo-FLP.R}F1A 
FBti0072900 
X-linked FLP 8727 
(BDSC) 
P{w[+mC] = ovo-FLP.R}M1A, 
w[*] 
FBti0072898 
msl-1 - y w; msl11/CyO - 
 
Table 2.1. Full genotype and stock numbers of Drosophila melanogaster 
strains used in this study. 
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Fig. 2.1. Mating scheme used to generate T(2;Y) translocations. The 3rd 
chromosome FLP source, [w+ovo-FLP], was balanced over TM3-Ser1 to enable 
translocations to be positively identified. In practice, the eye color of 
translocations is sufficiently dark as to be readily distinguished in the [w+ovo-
FLP] background. 
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P-element end Primer  Sequence 
Proximal 1A1 Plac1(+) CCAAGGCTGCACCCAAGGCTCTGCTCCCAC 
1A1_R1 CGTTCTGCCGGCAGCGAAGTCGACTG 
Distal 1A1 Pry4(+)  
 
TAATCAACAATCATATCGCTGTCTCACTCAG 
1A1_F1  
 
GAAGTGCGTGCGTGTGCGTGCGTC 
Proximal 2L at 
22A2 
Pry4(+) TAATCAACAATCATATCGCTGTCTCAC 
22A2_R1  GTGCTGCCCATCATCCTTATGCC 
Distal 2L at 
22A2 
Plac1(+) CCAAGGCTGCACCCAAGGCTCTGCTCCCAC 
22A2 _F1 CCGTCGCCTGCTGTGTACCGC 
 
Table 2.2. Primers used for molecular characterization of translocations. 
Pair of primers used at each P-element end is shown. 
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RESULTS AND DISCUSSION 
 We obtained insertions of specialized P-elements, P{RS3}  and P{RS5}, 
for the purpose of generating translocations (described in GOLIC and GOLIC, 
1996; see Table 2.1 for stock descriptions). These elements have FRT sites 
flanking the 5′ exon or 3′ exon, respectively, of the mini-white gene. Flies carrying 
intact elements have dark red eyes. FLP-mediated recombination between the 
flanking FRT sites deletes one exon to generate reduced P{RS3r}  and P{RS5r} 
elements, which retain a single FRT  site and the 3′ (RS3r) or the 5′ (RS5r) exons 
of the mini-white  gene. Flies with reduced elements have white eyes. 
 We used P{RS3}  elements with insertion sites at cytological positions 
22A2 and 25B1 on 2L , and 56C6 and 57B1 on 2R  from the Drosophila Genetic 
Resource Center (DGRC, Kyoto, Japan). Two P{RS5}  elements inserted in G9a  
at cytological position 1A1 on the tip of the X  chromosome were also obtained. 
Although these elements were believed to be close to one another, the mini-
white marker of one segregated with the Y chromosome (DGRC Stock# 125639). 
PCR confirmed that this stock had a P-element in G9a, as well as a copy of G9a 
lacking the insertion. This is consistent with insertion on Dp(1;Y)y+, the Y  
chromosome present in the strain used to generate the original insertions, which 
carries 1A1–1B on the Y  chromosome (personal communication, K Cook). This 
insertion has been renamed Dp(1;Y)y+, P{w[+mW.Scer\FRT.hs]=RS5}G9a[5-HA-
2731] y+ /w1118  and is now available from the Bloomington Drosophila Stock 
Center (BDSC #3649). We performed matings to determine whether the Y–linked 
FRT site could recombine with autosomal sites. The Golic laboratory has 
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demonstrated that the recovery of recombinants between non-homologous 
chromosomes is dramatically enhanced by a third FRT site (BEUMER et. al., 
1998). In accord with these findings, we were unable to obtain 2;Y translocations 
with 2 FRT sites (approximately 348 vials screened). We then generated flies 
carrying the Y–linked P{RS5r} element and 2 second chromosome P{RS3r}  
elements, one on 2L  and one on 2R . Both P{RS3r}  elements were oriented to 
enable production of 2;Y  translocations (Fig.2.1). Cytological and molecular 
analysis was then used to identify the 2nd chromosome break point. The number 
of vials scored for each set of endpoints and the translocations recovered are 
presented in Table 2.3. 
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2nd chromosome 
FRT sites 
# Vials 
scored 
Translocations 
recovered (#) 
Rate of recovery 
of translocations 
22A2 and 56C6 140 22A2 (3) 2.14% 
22A2 and 57B1 107 0 - 
25B1 and 56B6 105 0 - 
25B1 and 57B1 238 57B1 (1), 25B1 (1) 0.84% 
All 590 5 0.85% 
 
Table 2.3. Summary of recovery of translocations in this study. All dysgenic 
males carried a Y-linked FRT site and the indicated FRT sites on 2L and 2R. The 
rate of recovery of translocations was (# independently recovered translocations/ 
# vials scored)*100. 
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 FLP-mediated recombination between P{RS5r} and  P{RS3r} elements 
restores the mini-white marker, which segregates with the 2nd chromosome 
endpoint. Regeneration of w+ made it possible to rapidly screen for 
recombinants, as only recombinant flies had deep red eyes. Our mating utilized a 
3rd chromosome source of ovoFLP in an element that itself produced a deep 
orange eye color. A Serrate balancer, TM3-Ser1, was introduced to distinguish 
recombinants from flies carrying the FLP source. However, this proved 
unnecessary, as the reconstituted w+ marker was distinctive even in flies 
retaining the FLP chromosome. Use of an X –linked FLP source (BDSC # 8727) 
would obviate the need to distinguish male offspring with light and dark eyes. The 
Y-linked half of the translocation can be followed by the y+ marker, which 
continues to segregate with the Y chromosome. Both halves of the translocation 
are thus marked, making it possible to follow them independently in a yw 
background. Furthermore, each half of the translocation can be molecularly 
confirmed by amplification with genomic primers flanking the insertion sites and 
outward facing primers in the P{RS5}  and P{RS3}  elements (Fig. 2.2). Outward 
facing primers within each P-element and in flanking genomic sequence were 
used to confirm the second chromosome break point. A schematic of 
translocation between the Y-linked 1A1 insertion and the 22A2 insertion on 2L is 
depicted in Figure 2.2. Flies with both ends of the translocation were w+y+, and, 
when used as template for PCR amplification, produced amplicons from proximal 
and distal P-element ends for the 1A1 and 22A2 insertions (Fig. 2.2B). Males 
with 2 wild type second chromosomes, and thus carrying half of the translocation 
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as a duplication on the Y chromosome, were wy+. As expected, these males 
lacked PCR products from the distal end of the insertion in G9a and the proximal 
end of the second chromosome insertion (Fig. 2.2B). No adult w+y females were 
recovered from these stocks, indicating that these deficiencies are completely 
lethal. 
 We recovered 5 independent (2;Y) translocations with endpoints at 22A2 
(3), 25B1 (1), and 57B1 (1). Translocations were named by the 2nd chromosome 
break point, for example, T(2;Y) 25B1 . The rate of recovery of translocations 
was 0.85% (# independently recovered translocations/ # vials scored)*100 (Table 
2.3). This is comparable to previously reported translocation rates of 0.33 to 
0.97% (BEUMER et. al., 1998). 
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Fig. 2.2. Molecular characterization of T(2;Y)22A2. (A) The insertion of 
P{RS5r} in G9a is in Dp(X;Y)y+, containing 1A1–1B. The relative position of the 
y+ marker is depicted with respect to P{RS5r} (triangle) and the junction between 
X and Y material (zigzag). Primers that amplify proximal and distal ends of all 
insertions were used; for simplicity, only those that amplify distal 1A1 (D 1A1) 
and proximal P{RS3r} at 22A2 (P 22A2) are depicted. Upon translocation, w+ is 
reconstituted on the second chromosome. The template amplified by distal 1A1 
primers is now at the tip of the second chromosome. Separation of the 
translocation halves to produce Dp(2;Y) 22A2 removes the distal 1A1 and 
proximal 22A2 templates, but proximal 1A1 and distal 22A2 templates (primers 
not shown) are retained. (B) Amplicons produced by a fly carrying the complete 
T(2;Y)22A2 translocation (top). All four P-element ends are detected. Amplicons 
from a Dp(2;Y)22A2 fly identify only the proximal end of the Y-linked 1A1 
insertion and the distal end of the 22A2 insertion (bottom). 
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 Both halves of translocations are clearly visible on polytene squashes 
(Fig. 2.3A and B). All 3 translocations can be separated to create viable 
(Dp(2;Y)22A2) or subviable (Dp(2;Y)25B1 and Dp(2;Y)57B1) duplications. 
Duplications can sometimes be observed pairing with the wild type 2nd 
chromosomes (Fig. 2.3C). Translocation moves an X telomere from the Y 
chromosome to the tip of the truncated 2nd chromosome. This can be seen in a 
polytene preparation from the T(2;Y)57B1  translocation (Fig. 2.3D). Importantly, 
both translocation and duplication males retain all fertility factors on the Y 
chromosome, and are thus fertile. 
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Fig.2.3. Cytological characterization of 2;Y translocations. (A) Polytene 
preparations from a male larva with the T(2;Y) 22A2 translocation display one 2nd  
chromosome truncated at 22A2 (arrow). (B) The other half of the translocation is 
seen protruding from the chromocenter. (C) A male with Dp(2;Y)22A2 shows 
pairing of the duplication with both wild type homologs (black arrow). A visible 
connection between the duplication and the chromocenter is marked by a white 
arrowhead. (D) Translocation moves the X telomere from the Y chromosome to 
the second. This is marked by a white arrow in a T(2;Y)57B1 male. A white 
arrowhead marks the 2L telomere on the normal homolog. 
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 The w+ and y+ markers associated with each half of these translocations 
make it possible to maintain them by selection in a yw background. However, 
Dp(2;Y)22A2  is viable, indicating that smaller translocations will be at a risk for 
loss without selection. Translocations were initially balanced by mating 
exceptional XXY females to a CyO(In(2LR)O) second chromosome. While 
possible to create stocks with both sexes carrying balanced translocations, these 
are plagued by low fertility. To enable easier maintenance, translocations were 
balanced over an msl-1 mutation (Fig. 2.4 for mating strategy). Females 
homozygous for msl-1 are fully viable and fertile, however msl-1 is male lethal 
(BELOTE and LUCCHESI, 1980). The msl-1 gene, situated at 36F on 2L, is 
proximal to or on the opposite arm from translocation breakpoints, and thus is 
present on the translocated second chromosome but absent from separated 
duplications. Stocks balanced by this method are vigorous and easily maintained. 
To control the risk of recombination posed by rare XXY females, duplicate stocks 
are maintained and periodically inspected. The location of other male-specific 
lethal genes, such as mle (42A6) and msl-3 (65E4), suggests that all (2;Y) 
translocations and (3;Y) translocations on 3R, or 3L distal to 65E4, could be 
balanced by a similar strategy. 
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Fig. 2.4. Balancing T(2;Y) over msl-1. Translocations were generated in a yw 
background to enable detection of y+ and w+ markers. yw; msl-1 females are 
mated to males carrying a full translocation (y+w+). Sons carrying the full 
translocation are mated back to yw; msl-1 females to establish a stock that can 
be maintained indefinitely without constant selection. 																					
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CHAPTER 3 FUNCTIONAL ANALYSIS OF THE RECRUITMENT OF DOSAGE 
COMPENSATION BY X-LINKED SATELLITE REPEATS IN DROSOPHILA 
MELANOGASTER 
 
 This chapter is a manuscript in preparation (JOSHI S.S. and MELLER 
V.H., in preparation) 
INTRODUCTION 
Drosophila melanogaster females have two X chromosomes while males 
have an X and a Y chromosome. This leads to an imbalance in the ratio of X : 
autosome gene dosage (DISTECHE, 2012). Males increase expression from 
most X-linked genes approximately twofold in a process called dosage 
compensation (DISTECHE, 2012). This is brought about by the Male Specific 
Lethal (MSL) complex, which consists of five proteins and one of two redundant 
long non-coding RNAs called RNA on the X 1 and -2 (roX1 and roX2). The MSL 
complex modifies chromatin through deposition of the activating H4K16ac mark 
(SMITH et. al., 2000). The roX RNAs are essential for proper identification and 
subsequent compensation of the X chromosome in the nucleus (MELLER and 
RATTNER, 2002; DENG and MELLER, 2006).  
How the MSL complex is limited to the X chromosome is an intriguing and 
important question that remains unanswered. Co-transcriptional assembly of the 
MSL complex is thought to occur at sites of roX RNA transcription (KELLEY et. 
al., 1999).  This is followed by binding of the MSL complex to specific loci called 
Chromatin Entry Sites (CESs), which are functionally defined by their ability to 
retain binding of core MSL proteins in the absence of the complete complex 
(ALEKSEYENKO et. al., 2008). CESs contain the MSL Recognition Element 
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(MRE), a 21 base-pair, GA-rich, cis-acting DNA sequence required for MSL 
complex binding. The CLAMP protein is bound at MREs and tethers the 
assembled MSL complex (SORUCO et. al., 2013). The MSL complex then 
spreads to nearby actively transcribed genes through recognition of active 
chromatin marks (LARSCHAN et. al., 2007; SURAL et. al., 2008). This elegant 
model suffers from major drawbacks. For example, X-identification cannot be 
attributed solely to MREs, since they are only ~2 fold enriched on the X 
chromosome as compared to autosomes (ALEKSEYENKO et. al., 2006). The 
discovery of the zinc-finger CLAMP protein that serves as a physical mediator 
between the MREs and the MSL complex was a significant finding. But CLAMP-
bound MREs are observed on all chromosomes, hence CLAMP does not 
account for the exclusivity of the MSL complex for X chromatin (SORUCO et. al., 
2013). 
The presence of the roX genes on the X chromosome suggests a role in 
marking the X for compensation. Indeed, when inserted on an autosome, the roX 
genes recruit the MSL complex to flanking sites and bidirectional, non-contiguous 
spreading in the form of discrete polytene bands is observed (KELLEY et. al., 
1999). This could be considered analogous to the long non-coding Xist (X-
inactive specific transcript) RNA that marks the inactive X chromosome in 
mammalian dosage compensation. Xist is a part of the X inactivation center (Xic), 
a region that is necessary and sufficient to silence the entire chromosome 
(BROWN et. al., 1991; BROCKDORF et. al., 1991). However, when roX genes 
are deleted from the X and placed on an autosome, the roX RNA assembles with 
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the MSL complex and travels to the X chromosome, rescuing compensation. 
(MELLER and RATTNER, 2002). This indicates that, unlike the XIC, the roX 
genes by themselves are not sufficient to specify X identity. Exclusive X-
recognition by the MSL complex must therefore involve additional mechanisms. 
Our lab has previously shown that the siRNA pathway plays a role in X 
chromosome recognition during dosage compensation (MENON and MELLER, 
2009). This led to a quest for the source of the small RNAs involved in this 
process and the discovery that siRNA from a repetitive element that is strikingly 
enriched on the X chromosome enhanced X-identification by the MSL complex 
and rescued the lethality of roX1roX2 mutant males (MENON et. al., 2014).  
These clusters of repetitive sequences, the 1.688X repeats, are near exclusive to 
the X chromosome and unlike most satellite repeats, they are euchromatic. In 
this study, we chose a functional approach to test the ability of 1.688X to recruit 
dosage compensation.  
We postulated that the 1.688X repeats might act cooperatively with roX 
genes to identify X chromatin. The presence of hundreds of dispersed 1.688X  
repeats in X euchromatin makes testing the effects of individual repeats near 
impossible. Instead we tested the ability of roX1 and 1.6883F  (a repeat cluster 
located at cytological position 3F) to recruit compensation to an autosome. A 
transgene carrying roX1 and 1.6883F was inserted on an autosome. roX1 or 
1.6883F can be excised from the transgene, enabling a test of either element by 
itself. The full transgene recruits the MSL complex in cis, as does roX1 alone 
and, surprisingly, 1.6883F alone. All three transgenes increase expression of 
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nearby genes. Remarkably, all three transgenes were able to partially rescue a 
lethal autosomal deficiency of the homologous chromosome in males, but not in 
females; thus demonstrating the ability to recruit functional compensation to an 
autosome. We conclude that the 1.6883F repeats play a functional role in 
recruitment of dosage compensation in Drosophila melanogaster males. 
MATERIALS AND METHODS 
Cloning and transgene integration 
 The [>roX1> w+mC>1.6883F >] transgene was generated in the pUASTB 
vector by traditional cloning techniques (described in detail below). Injections 
were performed by Genetic Services Inc. (Sudbury, MA) into stocks containing 
22A3 [VK00037], 24A2 [su(HW)attP6] and 25C7 [attP40] landing sites. In-situ 
hybridization to polytene preparations using a 1.6883F probe verified integration 
(Appendix A).  
Fly culture and strains 
 Flies were maintained at 25°C on standard cornmeal agar diet in a 
humidified incubator. Strains carrying Df(2)22A2 have been described (JOSHI et. 
al., 2014). Description of P{Sqh-mCherry.M}  and P{sqh-GAL4} can be found at 
flybase.org. [hp 1.6883F] has been described (MENON et. al., 2014). 
Sorting and quantification of third instar larvae 
 Fly matings to generate scorable Df(2)22A2 male or female larvae are 
presented (Fig. 3.9). Fluorescent larvae inherited the intact 2nd chromosome, and 
dark larvae carried the deficiency. All third instar larvae were collected and 
scored 3 times per day. Males were identified by gonad visualization. A subset of 
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larvae was subjected to PCR to verify the Df(2)22A2. All non-fluorescent larvae 
did carry the deficiency (data not shown). 
Immunodetection 
 Immunhistochemical detection of MSL2 on polytene chromosomes was 
done as previously described (KELLEY et al. 1999). Visualization and 
photography were performed with an Olympus IX81 inverted microscope fitted 
with a Photometrics CoolSNAP EZ CCD camera. 
Quantitative RT-PCR 
 Total RNA was prepared from two biological replicates of ~50 third instar 
males per genotype using the Trizol reagent (Invitrogen). One microgram of total 
RNA was reverse transcribed using random hexamers and the ImProm-II reverse 
transcriptase following manufacturer recommendations (Promega). Duplicate 
reactions were amplified in a 20 µl volume (4 µl primer mix, 2 µl 1:10 template, 4 
µl DH2O and 10 µl iTaq Universal SYBR Green Supermix from Bio-Rad) using an 
Mx3000P Real-Time PCR system (Stratagene). Genes selected for analysis 
were stably and moderately expressed during the third instar larval stage (genes 
and primer information in Table 3.1). qRT-PCR data was analyzed by the 
efficiency corrected comparative quantification method (PFAFFL 2001), primer 
efficiency was incorporated into calculations. Dmn was used as the normalizing 
gene. A box and whiskers plot was generated using SPSS. One-way ANOVA 
was performed followed by Tukey’s HSD post-hoc tests for analysis of significant 
difference between means of gene expression values. SPSS was used to 
calculate Pearson correlation coefficients of relationship between change in gene 
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expression, and distance from the transgene or basal expression.  
Generation of the SJTG clone 
 The SJTG clone contains roX1 and 1.6883F, each flanked by LoxP and 
FRT sites, with w+mC between them. After integration using phiC31, the transgene 
had [>roX1> w+mC>1.6883F >] in the orientation shown. FRT sites were amplified 
from flies containing a PBac transposable element using roX1_Frt_F and 
roX1_Frt_R, and Sat_Frt_F and Sat_Frt_R, to produce FRT sites flanking roX1 
and 1.6883F respectively. PCR products were cloned into the pCR4-TOPO vector 
(Invitrogen). LoxP sites were amplified from the plasmid pRKO using 
roX1_LoxP_F and roX1_LoxP_R, and Sat_LoxP_F and Sat_LoxP_R, to produce 
LoxP sites flanking roX1 and 1.6883F respectively. PCR products were cloned 
into the pCR4-TOPO vector. roX1-LoxP was excised at BamHI and NotI and 
cloned into pBluescript containing a 4.9kb roX1 fragment. roX1 was then excised 
from this vector using EcoRI on each side, as it contains a ClaI site. FRT was 
dropped in using ClaI and SalI, and roX1 was put back using EcoRI to produce 
the “LFR” clone (roX1 flanked by LoxP and FRT). Sat-LoxP was excised using 
EagI and cloned into the NotI site of a pCR4-TOPO vector containing a ~2kb 
1.6883F fragment. Sat-FRT was then cloned into this vector using PstI and SpeI, 
generating the “LFS” clone (1.6883F flanked by LoxP and FRT). The vector 
pUASTB contains P-element ends, a w+mC and an attB site (GROTH et. al., 
2004). The StuI site in pUASTB was opened and a linker was put in containing a 
XhoI site, destroying the StuI site in the process. “LFS” was digested with SalI to 
excise a ~2.5 kb fragment containing 1.6883F, LoxP and FRT and this fragment 
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was inserted into pUASTB at the XhoI site. This clone was then digested with 
MluI; and a ~5.4 kb fragment containing roX1, LoxP and FRT was excised from 
“LFR” using BssHII and inserted. The final clone, “SJTG” was thus generated. 
Extensive restriction mapping, sequencing and PCR were performed at each 
stage of the cloning for confirmation.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
		
30	
Primer name Sequence 
roX1_LoxP_F ATCGGTCGGCGGCCGCGCGCTTAATATAACTTCGTATAATGTA 
roX1_LoxP_R GATGGATCCCCTAATAACTTCGTATAGCAT 
Sat_LoxP_F ATCGTTCGGCCGTCGACTTAATATAACTTCGTATAATGTA 
Sat_LoxP_R CGACCGTTGCGGCCGCCCTAATAACTTCGTATAGCAT 
roX1_Frt_F CCATCGATACTAGTTTCCGAAGTTCCTATTCTC 
roX1_Frt_R GCATGCGCGCGCGCGCTCTGAAGTTCCTATACT 
Sat_Frt_F GACTGCAGCGGCCGCTTCCGAAGTTCCTATTCTC    
Sat_Frt_R CACTAGTGTCGACGCTCTGAAGTTCCTATACT 
BPR08wh(F) TAGCTCCTGATCCTCTTG 
RNR1_R2 AAAACAGTCTTCATTTAAGCGGTAA 
roX1HincIIR CTCAATAGCATAAAAAATAGTTGACC 
attB_210R TGACCGTCGAGAACCCGCTGACG 
BPR26 GAGGTCTAGACCCACCAAAGAGGCTTGACAGAAGA 
roX1R_706 TCATATCCACTAGCATAAGGCTGGCG 
 
        Table 3.1. List of primers used in cloning and analysis of  
        [>roX1>w+mC>1.6883F >]. 
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RESULTS  
Our initial working model was that the X-linked roX genes recruit 
compensation in cis and X-linked satellites facilitate spreading to cover the X 
chromosome. To test this we generated a transgene with roX1 and 1.6883F 
[>roX1> w+mC>1.6883F >]. LoxP and FRT sites (>) enable deletion of roX1 or 
1.6883F by site-specific recombination (Fig. 3.1).  Excision is detected by loss of 
w+mC. Genotypes of flies and excised transgenes were confirmed by PCR (data 
not shown). Full and reduced transgenes were integrated on 2L at cytological 
positions 22A3, 24A2 and 25C7 (superscript indicates cytological position, see 
materials and methods for details). The full transgene is henceforth referred to as 
[roX1+1.6883F]; and the reduced transgene with roX1 as [roX1]; and 1.6883F as 
[1.6883F].  
 1.6883F and roX1 transgenes recruit MSL protein to autosomal sites 
Male polytene chromosome preparations were made from a laboratory 
reference strain with no transgenes and from strains with full or reduced 
integrations at 22A3. These were immunostained for the core MSL complex 
component MSL2. As expected, all polytenes showed strong recruitment to the X 
chromosome. No autosomal recruitment of MSL2 to 2L was detected in the 
laboratory reference strain (Fig.3.1 B, C). In contrast, males carrying complete 
and reduced transgenes displayed recruitment to the tip of 2L at cytological 
position 22A3 (Fig. 3.1 D-G). Quantification of the recruitment was performed 
and the results are presented in Table 3.2, while examples of weak (+) to very 
strong (++++) recruitment are shown in Fig. 3.2. Recruitment of MSL2 by 
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[1.6883F]22A3 was more robust than [roX1]22A3, and comparable to 
[roX1+1.6883F]22A3. Significantly, [1.6883F]22A3 and [roX1+1.6883F]22A3 support 
spreading of MSL2 into chromatin of 2L.  This is particularly apparent at a strong, 
subtelomeric band that is seen in most preparations with these transgenes, but 
not in control males (white arrowheads, Fig. 3.1 E, G; Table 3.2). It has 
previously been shown that the subtelomeric position 21B weakly recruits MSL2 
in wild type males, but the low resolution of polytene preparations does not allow 
us to conclude that this is identical to the subtelomeric band presently observed  
(MELLER and RATTNER, 2002). Interestingly, about half the preparations of 
[1.6883F ]22A3  and [roX1+1.6883F]22A3 also showed spreading to an additional 
autosomal telomere, specifically 3L (white arrows, Fig. 3.3). Although [roX1]22A3 
did not support robust spreading to the sub-telomeric band on 2L, ~ 20% of 
preparations showed  proximal spreading on 2L. Moreover, a chromosome 
having the complete transgene integrated at three positions, 
[roX1+1.6883F]22A3+24A2+25C7, recruited MSL2 as individual bands of comparable 
intensity near each integration site, and spreading was observed in the form of a 
single sub-telomeric band (data not shown).  
roX transgenes, which contain CES sites, have long been known to recruit 
the MSL complex and induce variable levels of MSL complex spreading into 
flanking chromatin (KELLEY et al., 1999). Transgenes containing the MRE motif 
also recruit the MSL complex to autosomes (ALEKSEYENKO et. al., 2008). Our 
study reveals that 1.6883F, which shares no sequence similarity with CES sites or 
MREs, is capable of recruiting the MSL2 protein near its site of integration when 
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present on an autosome. Moreover, [1.6883F]22A3 supports spreading in cis, in the 
form of additional bands on polytene chromosomes.  We conclude that the 
1.6883F repeats do not merely facilitate spreading, but are themselves capable of 
recruiting the MSL complex to nearby chromatin. 
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Figure 3.1. Autosomal insertion of roX1 or 1.6883F recruits MSL2.                
(A) Schematic of roX1 and 1.6883F transgenes. The complete transgene (top) 
has roX1, w+mC and 1.6883F flanked by attL and attR sites (open rectangles). 
LoxP sites (gray triangles) enable Cre-mediated excision of 1.6883F and w+mC, 
producing white-eyed roX1 flies (bottom left). FRT sites (black triangles) enable 
excision by FLP to remove roX1 and w+mC, to generate white-eyed 1.6883F  flies 
(bottom right). (B) MSL recruitment (red) is limited to the X chromosome in a 
control male. (C) Enlargement of cytological position 22A3 showing absence of 
MSL2 (yellow arrowhead). (D) [roX1]22A3 recruits MSL2 to a single band near 
22A3. (E) [1.6883F ]22A3 recruits MSL2 robustly near the integration site (yellow 
arrowhead). Spreading to a sub-telomeric region is observed (white arrowhead). 
(F, G) MSL2 recruitment by [roX1+1.6883F ]22A3 is robust and similar to [1.6883F 
]22A3. (G) Detail of 2L from (F). Immunostaining was performed to polytene 
chromosomes from male third instar larvae. DNA is counterstained using DAPI 
(blue). X-staining of all transgenic lines is indistinguishable from that in wild type 
males.  
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 Transgene 
22
A
3 
R
ec
ru
itm
en
t 
 None roX1 1.6883F roX1 + 
1.6883F 
- 100 (63) 0 (0) 0 (0) 1.01 (1) 
 
+ 0 (0) 10.78 (11) 0 (0) 0 (0) 
 
++ 0 (0) 65.68 (67) 15.17 (17) 30.3 (30) 
 
+++ 0 (0) 23.52 (24) 55.35 (62) 59.59 (59) 
 
++++ 0 (0) 0 (0) 29.46 (33) 14.14 (14) 
 
A
dd
iti
on
al
 
si
gn
al
 o
n 
2L
 None 98.41 (62) 75.49 (77) 9.82 (11) 15.15 (15) 
 
Sub-telomeric 0 (0) 6.86 (7) 89.3 (100) 78.78 (78) 
 
Proximal to 
22A3 
1.5 (1) 19.6 (20) 8.03 (9) 4.04 (4) 
 
3L
 
te
lo
m
er
e None 98.41 (62) 95.09 (97) 49.1 (55) 45.45 (45) 
 
One Band 1.58 (1) 3.92 (4) 50.89 (57) 54.54 (54) 
 
O
th
er
 Ectopic bands 
on other chr 
3.17 (2) 36.27 (37) 7.14 (8) 9.09 (9) 
X-staining 
normal 
100 (63)  100 (102) 100 (112) 100 (99) 
Total nuclei counted 63 102 112 99 
  
 Table 3.2. Autosomal MSL2 recruitment by [roX1]22A3;  [1.6883F]22A3 and   
 [roX1+1.6883F]22A3. Recruitment close to the integration site is ranked from no 
 recruitment (-) to very strong (++++). Additional autosomal signals were  
 categorized by cytological position. Examples of the various categories of 
 recruitment are presented in Fig. 3.2. The percentage of nuclei in each category 
 is followed by the number of nuclei (parentheses). Counts were derived from 3  
 individuals for yw, and 5 each for  [roX1]22A3;  [1.6883F]22A3 and [roX1+1.6883F]22A3. 
 Scoring was done by a single individual on coded samples.  
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Fig. 3.2. Examples for varying degrees of MSL2 staining by autosomal   
transgenes. Representative images showing MSL2 recruitment ranging from 
weak (+) to very strong (++++) as quantified in Table 3.2.  
+ ++ 
+++ ++++ 
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Fig. 3.3 MSL2 spreading to the 3L telomere. MSL2 (red) is recruited by 
[1.6883F ]22A3 (A) and [roX1+1.6883F ]22A3 (B). Recruitment near the integration site 
(yellow arrowhead) and robust telomeric recruitment to 2L (white arrowhead) and 
3L (white arrows) is observed. Immunostaining of polytene chromosomes from 
male larvae used an anti-MSL2 antibody. DNA was counterstained with DAPI 
(blue).  
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Increased autosomal gene expression is observed near transgene 
integrations 
Recruitment of MSL2 to 2L by roX1 and 1.6883F integrations suggested a 
possible increase in expression of nearby genes in males. To test this we 
generated recombinant chromosomes with all three complete integrations 
([roX1+1.6883F]22A3+24A2+25C7), increasing the number of genes near integration 
sites that could be tested. Expression of Cre or FLP then produced 
chromosomes with roX only ([roX1]22A3+24A2+25C7) or 1.6883F only 
([1.6883F]22A3+24A2+25C7) integrations. Quantitative RT-PCR was used to measure 
expression of test genes situated near integration sites in male larvae (see Fig. 
3.4 for schematic; Table 3.3 for genes and primers; Table 3.4 for relative gene 
expression values). Control autosomal genes, situated far from the integration 
sites (2R or 3R) showed no difference in expression between lines with 
transgenes and our lab reference strain (white boxes, Fig. 3.4).  In contrast, 
genes near integration sites displayed a slight increase in expression in 
[roX1]22A3+24A2+25C7 males (gray box, Fig. 3.4).  Interestingly, these genes 
displayed a greater, statistically significant increase in   [1.6883F ]22A3+24A2+25C7 
males.  As expected, males with 3 copies of the full transgene had the largest 
increase in expression of nearby genes (gray boxes, Fig. 3.4).  
The most highly expressed gene tested, RpL37A encoding a ribosomal 
subunit, displayed a 2-fold increase in expression, as would be expected from full 
compensation.  As local MSL complex recruitment is cotranscriptional, strong 
expression of RpL37A may facilitate increased MSL complex recruitment. In 
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accord with this idea, we found a positive correlation between expression relative 
to Dmn in control males, and the increase in expression achieved when roX1 and 
1.6883F transgenes are present (Fig.3.5 A-C). We did not, however, observe a 
correlation between the distance to the nearest transgene and the increase in 
expression achieved, up to a distance of 142 Kb, which is the farthest our test 
genes were from the integration site. (Fig.3.5 D-F). We conclude that local MSL2 
recruitment induced by roX1 and 1.6883F transgenes increases the expression of 
genes in cis, reflecting the presence of an active MSL complex. 
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Fig. 3.4. Expression of autosomal genes near transgene integration sites is 
increased in male larvae. (A) Schematic showing test genes near transgene 
integrations (black triangles) on 2L. (B) Expression was measured by quantitative 
RT-PCR in third instar male larvae. The ratio of expression in males with the 
indicated transgenes to control males (no transgenes) is depicted for 10 test 
genes (near integration sites on 2L, gray) and 5 control genes (on 2R or 3, 
white). The control genes show no significant change in expression when 
transgenes are integrated on 2L. Test genes on 2L significantly increased in 
expression in [1.6883F]22A3+24A2+25C7 and [roX1+1.6883F]22A3+24A2+25C7 males (* 
p<0.05 and ** p<0.01 respectively).  
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Fig. 3.5. 1.6883F-dependent increase in gene expression is correlated with 
basal expression but not distance from nearest transgene. (A-C) 
Scatterplots showing relationship between gene expression in control males (no 
transgene; X-axis) and the change in expression in males with a transgene (Y-
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axis). All expression is normalized to Dmn. A significant correlation is observed 
for [1.6883F]22A3+24A2+25C7 (B) and [roX1+1.6883F]22A3+24A2+25C7 (C) but not 
[roX1]22A3+24A2+25C7 (A), however a trend can be observed. (D-F) Scatterplots 
showing distance to nearest transgene (X-axis; in Kb) and the change in 
expression in males with a transgene (Y-axis). No significant correlation was 
detected in this analysis. Pairwise correlation was performed using SPSS, the 
Pearson Correlation Coefficient (R) is shown. (* p < 0.05) 
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Gene 
name 
Cytological 
position 
Primer 
name 
Primer sequence Primer 
Working 
conc. 
(nM) 
Efficiency 
(%) 
CG33128 22A2 (2L) J1_F2 AACCGACCAGAA
CCTCATCG 
150 98.4 
J1_R2 TCACGGTTCCAT
TCCAGGTG 
RFeSP 22A3 (2L) J2_F3 AAATGATGAACG
CCGTGTCG 
300 89.2 
J2_R3 GCAGAGCCTTAC
CCATCGAG 
Eno 22B1 (2L) J3_F1 ATGTCTTGGACC
GCTTCAGT 
150 102.1 
J3_R1 GCCCTTTCGATT
GGGGTGA 
CG16704 24B1 (2L) J4_F3 GAATGGTCTCGC
TGTGTTGTG 
150 106.5 
J4_R3 TAGGTCCACATG
GGTTGCAG 
eIF-3p40 25C3 (2L) J5_F2 ACGGACTGGTG
AGTAGTGCT 
150 98.3 
J5_R2 CTCTACGCCCAT
GTCCTCAC 
His3.3A 25C3 (2L) J6_F2 GCGTCTCTCCCC
CATTTCAA 
150 106.8 
J6_R2 CATAATGGTGAC
GCGCTTGG 
Rpn11 25C3 (2L) J7_F2 CAGAGGTGAGC
ACTTGGCTTA 
150 102.7 
J7_R2 TGTGGCATAGCA
CCTCCAAG 
RpL37A 25C4 (2L) J8_F1 GAGCGCCAAAT
GGTGACAAA 
500 108.6 
J8_R1 CAGGACCAGAT
GCCCACAAC 
Trip1 25B5 (2L) J9_F4 TCACAGGTTGGT
GTTTACCCG 
500 111.8 
J9_R4 GTGCCAGAGTCA
ACCACCTT 
CG31778 24C1 (2L) J10_F2 AACCATTCACTG
CAGAGGCG 
150 95.7 
J10_R2 CCGAAGTCATTG
CCCTCAGAA 
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Gene 
name 
Cytological 
position 
Primer 
name 
Primer sequence Primer 
Working 
conc. 
(nM) 
Efficiency 
(%) 
Dip-B 87F13 (3R) DipB_F AGGATCACGCCA
GAAGACTG 
300 92.8 
 
DipB_R AGTCACTGGGAC
GGAGAATG 
ATPa 93A4 (3R) ATPa_F ACCCACACTGCT
ACACTCCC 
300 106.3 
ATPa_R TCCTGGTTGCTC
TTGTTGTG 
Xbp1 57C3-C4 
(2R) 
Xbp1_F GGGAGAGCAAC
TTTGACGAG 
300 97.1 
 
Xbp1_R GCCGGCCAAAC
TTAACAATA 
Gprk1 41B3-C2 
(2R) 
Gprk2_F1 TCTAAAAGGCTT
GGGTGCAT 
300 97.2 
Gprk2_R1 TGTAAACCTGGT
GCCAATCA 
Gapdh1 
 
43E17 (2R) GAPDH_F GCCCTGAACGG
CAAGCT 
300 98.9 
 
GAPDH_R GTAAGATCCACA
ACGGAGACATTG 
Dmn 44F3 (2R) Dmn_F GACAAGTTGAGC
CGCCTTAC 
300 98.5 
 
Dmn_R CTTGGTGCTTAG
ATGACGCA 
 
  Table 3.3. List of primers used for quantitative RT-PCR studies. The genes on 
2L were used as test genes and genes on 2R and 3R were used as controls in this 
study. Dmn was used as the normalizing gene. 
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Gene 
Transgene  
None roX1 1.6883F  roX1+1.6883F   
Te
st
 G
en
es
 o
n 
2L
 
CG33128 1 1.263 1.11 1.208 1.326 1.425 1.337 
RFeSP 1 1.192 1.242 1.368 1.29 1.63 1.49 
Eno 1 1.096 1.184 1.14 1.26 1.31 1.51 
CG16704 1 1.096 1.06 1.12 1.098 1.204 1.133 
eIF-3p40  1 0.998 1.1 1.09 1.25 1.37 1.26 
His3.3A  1 1.49 1.612 1.45 1.348 1.59 1.474 
Rpn11 1 0.862 0.824 0.96 0.935 0.99 0.92 
RpL37A 1 1.412 1.478 1.762 1.696 1.88 2.069 
Trip1 1 1.408 1.48 1.51 1.592 1.672 1.761 
CG31778 1 1.396 1.484 1.689 1.745 1.533 1.594 
C
on
tr
ol
 G
en
es
 o
n 
2R
 a
nd
 3
R
 
Xbp1 1 0.954 0.943 0.92 0.894 0.902 0.88 
DipB 1 0.844 0.876 1 0.912 0.912 0.993 
ATPa 1 1.178 1.192 1.107 1.11 1.116 1.143 
Gprk2 1 1.115 1.084 1.098 1.12 1.108 1.033 
GAPDH 1 1.102 1.196 1.086 1.162 1.14 1.092 
 
 
Table 3.4. Relative gene expression values. Gene expression as measured by 
 quantitative RT-PCR. RNA was extracted from control male third instar larvae; or 
 from males with integrations of [roX1], [1.6883F], or [roX1+1.6883F] transgenes. 
 Expression from yw (No TG) was used as a calibrator, and Dmn was used as the 
 normalizer. Two biological and two technical replicates were performed. 
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1.6883F and roX1 transgenes functionally compensate a 2L deficiency 
To determine if the observed increase in expression of autosomal genes 
constituted a functional dosage compensation system, we tested for rescue of 
lethality associated with a hemizygosity of distal 2L. Males with a lethal 2nd 
chromosome deficiency and a single [roX1+1.6883F]22A3 transgene on the intact 
homolog opposite the deficiency were generated. As the dosage compensation 
complex is only assembled in males, females are used as the control (Fig.3.6 A). 
We selected a translocation (T(2;Y)22A2) that can be separated into its 
constituent halves; a terminal deficiency of 1.5 Mb that is completely lethal 
(Df(2)22A2), and a reciprocal duplication on the Y chromosome (Dp(2:Y)22A2) 
(JOSHI et. al., 2014). Matings that separate Df(2)22A2 and Dp(2:Y)22A2 
produce offspring for testing (Fig. 3.7). Df(2)22A2 has its endpoint at cytological 
position 22A2, therefore we chose to test a transgene integration at 22A3.  
 Neither full nor reduced transgenes at 22A3 rescued Df(2)22A2 males to 
adulthood. Nor could adult male survivors having Df(2)22A2 be recovered when 
three copies of the transgene on 2L were integrated at 22A3, 24A2 and 25C7 
(data not shown). This may be a consequence of the insertion sites at 24A2 and 
25C7 being several Mb away from the deficiency endpoint that is at 22A2. 
However, closer examination of the vials revealed pharate male pupae, and a 
few partially eclosed males carrying Df(2)22A2 over a single integration of the 
transgene at 22A3. No pharate Df(2)22A2 males were observed from matings 
that lack the transgene and no pharate females could be recovered with or 
without the transgene (Fig. 3.6 B; data not shown). Dissection of the pupal cases 
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of pharate males revealed fully developed adults with eye color indicating the 
Df(2)22A2 chromosome. The presence of Df(2)22A2 and lack of  Dp(2:Y)22A2 in 
these males was confirmed by PCR (Fig. 3.8). While both the partial and 
complete transgenes enabled recovery of pharate males; [roX1]22A3 yielded 6% 
the anticipated number of pharate males (based on survival of brothers lacking 
Df(2)22A2), and [roX1+1.6883F]22A3 produced 18% pharate males.  The most 
dramatic finding was that the repeats alone, [1.6883F ]22A3 produced 11% pharate 
survival, exceeding rescue with roX1 alone (Fig. 3.6 B). These findings suggest 
that roX1 and 1.6883F transgenes were achieving partial compensation of 2L, but 
the difficulty of scoring pharate pupae prompted a switch to examination of 3rd 
instar larvae.  
Larval survival is enhanced by 1.6883F and roX1  
To determine if differences in survival can be detected at earlier 
developmental times, we sexed and genotyped all late 3rd instar larvae from 
matings that produce Df(2)22A2 males and females (see Fig. 3.9 for mating 
strategy). Larvae were sexed and genotyped by visible markers, and a subset of 
Df(2)22A2 males were genotyped by PCR. PCR revealed the presence of the 
deficiency and absence of the rescuing duplication in these males (Data not 
shown). 3rd instar Df(2)22A2 females were recovered at  ~ 3% the anticipated 
number in vials from control matings in which no roX1or 1.6883F transgene is 
present on 2L. The recovery of these females is unchanged by the 
[roX1+1.6883F]22A3 integration (Fig. 3.6 C).  Df(2)22A2 males with no transgene 
are also recovered at ~3%. However, when [roX1]22A3 was present on the intact 
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2nd chromosome, 20% of Df(2)22A2 3rd instar males were recovered (black bar, 
Fig. 3.6 D). This increased to 36.5% with [1.6883F ]22A3. Optimum recovery of 51% 
of 3rd instar Df(2)22A2 males was achieved with [roX1+1.6883F]22A3 (black bars, 
Fig. 3.6 D). These findings confirm that the 1.6883F repeats are more effective in 
recruiting compensation to nearby genes than roX1 itself.  
Ectopic expression of 1.6883F siRNA enhances rescue of male larvae when 
a cognate sequence is present on 2L 
 Our lab has previously shown that ectopic expression of hairpin RNA from 
1.6883F led to production of small RNA and partially rescued the lethality of 
roX1roX2 mutant males. We speculate that 1.6883F siRNA might act by triggering 
modification of chromatin at related repeats throughout the X, and that these 
epigenetic changes facilitate recruitment of MSL proteins to nearby genes. The 
presence of 1.6883F on the autosomal transgene enabled us to test if the effect of 
hp1.6883F on compensation requires cognate loci near regulated genes. If this is 
the case, we would expect any effect of hp1.6883F expression to be limited to 
transgenes that carry 1.6883F repeats. In accord with this prediction, ectopic 
expression of 1.6883F siRNA had no effect on the recovery of male larvae 
carrying Df(2)22A2 with [roX1]22A3 on the intact chromosome (gray bars, Fig. 3.6 
D). However, an 8% increased recovery of larvae carrying Df(2)22A2 over 
[1.6883F ]22A3 or [roX1+1.6883F]22A3 was observed when hp1.6883F was expressed 
(gray bars, Fig. 3.6 D).  The effect of 1.6883F siRNA was thus limited to 
transgenes containing 1.6883F. Expression of hpRNA to the non-essential white 
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gene did not affect rescue by any transgene, indicating that enhanced rescue is 
not an effect of non-specific small RNA production (preliminary data, not shown). 
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Fig. 3.6. Insertions of roX1 and 1.6883F on 2L partially rescue males 
carrying a lethal 2L deficiency. (A) Strategy to test autosomal dosage 
compensation. Df(2)22A2 is lethal in both males (left, top) and females (right, 
top). If a roX1 and 1.6883F transgene on the homolog recruits dosage 
compensation, male-limited rescue will occur (left, bottom). Thick lines indicate 
dosage compensated chromatin. (B) Pharate Df(2)22A2 males are observed only 
when [roX1]22A3, [1.6883F ]22A3  or [roX1+1.6883F]22A3 is present on the homolog. 
The recovery of pharate males is with respect to the number of brothers that 
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emerge with the intact 2nd chromosome (See Fig. 3.7 for description of mating). 
(C) Recovery of female larvae (diagonal lines) was unaffected by the presence of 
[roX1+1.6883F]22A3. (D) Recovery of Df(2)22A2 male larvae is enhanced by 
transgenes containing roX1 and 1.6883F, and ectopic hp1.6883F RNA. The ratio of 
larvae carrying Df(2)22A2 to their siblings with an intact 2nd chromosome is 
presented (See Fig. 3.9 for description of mating). 2nd chromosome integrations 
of [roX1]22A3 ; [1.6883F ]22A3 and [roX1+1.6883F]22A3 significantly increased the 
number of male larvae recovered (black bars). Ectopic expression of hp1.6883F 
RNA further enhanced recovery of male larvae with [1.6883F ]22A3 and 
[roX1+1.6883F]22A3, but not [roX1]22A3 (gray bars) (Fig. 3.10 for description of 
mating). SEM represented by error bars. (* p < 0.05; ** p < 0.01; *** p < 0.001; 
**** p < 0.0001).  
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Fig. 3.7. Matings to test transgene rescue of male Df(2)22A2 flies. Male 
Df(2)22A2 offspring were generated by mating C(1)DXyf females homozygous 
for the transgene to be tested [TG] to T(2;Y)22A2 males. T(2;Y)22A2 can be 
separated into Df(2)22A2 and Dp(2;Y)22A2 (JOSHI et. al., 2014).  All male 
progeny inherit a wild type maternal Y chromosome, the 2nd chromosome 
transgene and either Df(2)22A2 (test males) or a wild type 2nd chromosome 
(control males). The 2L endpoint of T(2;Y)22A2 carries a white marker, 
conferring dark red eye color which enables phenotypic distinction. 
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Fig. 3.8. PCR genotyping of a pharate male. PCR detecting the proximal and 
distal ends of the insertions used to generate T(2;Y)22A2. The translocation 
occurred between an insertion in 2L and an insertion at 1A1 in a small duplication 
of the distal X on the Y (JOSHI et. al., 2014). Amplicons from a representative 
Df(2)22A2 pharate male are shown. The distal 1A1 (lane 3) and proximal 22A2 
(lane 6) PCR products can be amplified from Df(2)22A2. The proximal 1A1 (lane 
4) and the distal 22A2 (lane 5) PCR products are indicative of Dp(2;Y)22A2 and 
not detected. A MW marker (lane 1) and PCR for template control (lane 2) are 
shown. 
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Fig. 3.9. Matings to determine recovery of Df(2)22A2 larvae. (A) Df(2)22A2 
male larvae were produced by mating C(1)DXyf females with the transgene to be 
tested [TG] to T(2;Y)22A2 males carrying P{Sqh-mCherry.M} on the intact 2nd 
chromosome.   All male progeny inherit a wild type, maternal Y chromosome, the 
transgene being tested and either Df(2)22A2 or P{Sqh-mCherry.M} (control). 
Males are identified by gonad visualization, and control males are detected by 
mCherry fluorescence. (B) Df(2)22A2 female larvae were produced by mating 
females homozygous for the transgene to be tested to T(2;Y)22A2 males 
carrying P{Sqh-mCherry.M} on the intact 2nd chromosome.  All female progeny 
inherit one copy of the transgene and either Df(2)22A2 or P{Sqh-mCherry.M} 
(control). Control females are detected by mCherry fluorescence. 
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Fig. 3.10. Matings to determine effect of hp1.6883F RNA on recovery of 
Df(2)22A2 males. C(1)DXyf females homozygous for the transgene to be tested 
were mated to T(2;Y)22A2 males carrying a UASgal-driven hp1.6883F RNA 
transgene (MENON et. al., 2014), and [Sqh-Gal4] on the X chromosome. P{Sqh-
mCherry.M} marks the intact 2nd chromosome. All male progeny ectopically 
express hp1.6883F, carry a wild type Y chromosome, a 2nd chromosome 
transgene and either Df(2)22A2 or P{Sqh-mCherry.M} (control). Control males 
are detected by mCherry fluorescence. 
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We conclude that 1.6883F functions as a cis-acting element for recruitment 
of the MSL complex, and dosage compensation, to flanking chromatin. The 
enrichment of related elements on the X chromosome suggests that this family 
broadly serves to mark X chromatin. Enhancement of rescue by hpRNA from 
1.6883F is limited to transgenes with cognate repeats suggesting that the siRNA 
pathway acts in dosage compensation via targeting of cognate loci on the X 
chromosome.  
DISCUSSION 
Although the MSL complex perfectly identifies active X chromatin in the 
interphase nucleus, how the appropriate selectivity is achieved remains 
mysterious. In this study, we have demonstrated that the 1.6883F satellite repeat 
is capable of facilitating recruitment of the MSL complex to nearby autosomal 
genes, leading to functional dosage compensation. This suggests that the 
presence of 1.6883F, and possibly other 1.688X repeats on the X chromosome, 
contribute to its distinctive identity.  
Recruitment and spreading of the MSL complex at autosomal transgenes 
 A roX1 transgene inserted on an autosome, in a roX1roX2 mutant 
background, recruited the MSL complex to the autosomal integration site, and bi-
directional, non-contiguous spreading of the MSL complex as well as H4K16 
acetylation was observed (KELLEY et. al., 1999). This suggested an increase in 
gene expression in the vicinity (KELLEY et. al., 1999). This was shown to be true 
a couple years later, albeit with the use of a reporter system (HENRY et. al., 
2001).  Insertion of roX1 and/or roX2 transgenes on an autosome led to 
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increased expression of an adjacent lacZ reporter gene, but a full two-fold 
increase in expression was very rarely observed. This was attributed to 
differences in local chromatin environment (HENRY et. al., 2001). It was later 
demonstrated by microarray and RT-PCR analyses that the presence of an 
autosomal roX transgene led to recruitment and spreading of the MSL complex in 
the vicinity, leading to an almost two-fold increase in gene expression (PARK et. 
al., 2010). Our findings in the current study are consistent with previous 
observations. With wild type roX genes present on the X chromosome, we 
observed that an autosomal transgene containing roX1 only recruited the MSL 
complex to the autosome in the form of a sharp band, and spreading to 
neighbouring polytene bands was not observed. However, when 1.6883F was 
present on the transgene along with roX1, we observed consistent spreading to a 
distal polytene band. This indicates that the repeats may enhance the spread of 
the MSL complex. In the Park et. al. study, rescue of a haplo-insufficient 
phenotype of the Minute gene was observed, but only in a roX-  mutant 
background. While we also observed rescue of a haploinsufficient phenotype 
with a transgene containing roX only, our system was, in fact, completely wild 
type for the canonical dosage compensation machinery.  
X-limited distribution of the satellite repeats 
 1.6883F is one of hundreds of similar repeats that are broadly distributed 
on euchromatic portions of the X chromosome (KUHN et. al., 2012). They are 
generally arranged in clusters of 1-4 units. Owing to the near-exclusive X-
localization of a sub-family of these repeats, they have been postulated to act in 
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dosage compensation (WARING and POLLACK, 1987; DIBARTOLOMIES et. al., 
1992). In D. melanogaster, chromosome-specific satellite repeats are strikingly 
enriched on the X chromosome, accounting for 45 times more coverage than the 
autosomes (GALLACH, 2014). This is also true for other Drosophilid species in 
which the copy number, length and sequence of these repeats vary, but 
enrichment on the X is conserved. Interestingly, the newly evolved X 
chromosome arm in D. pseudoobscura rapidly acquired satellite repeats that are 
also found on the ancestral X (GALLACH, 2014). The mechanism by which these 
repeats proliferate is unknown, but our current study suggests a potential 
mechanism that would restrict them to the X chromosome. As D. melanogaster 
autosomal 1.688X repeats will cause misregulation of nearby genes in males, and 
thus become targets of natural selection.  
How do the 1.688X act in dosage compensation? 
Previous studies have identified a single class of DNA elements as 
instrumental in MSL recruitment. These are the MREs, a component of the CES. 
The CES were identified based on their ability to recruit a core MSL complex 
consisting of MSL1 and MSL2 (ALEKSEYENKO et. al., 2006). This recruitment is 
based on the presence of the MRE motif, which is bound by the adaptor protein 
CLAMP. How 1.6883F contributes to MSL recruitment is currently unknown. We 
hypothesize that the CES and 1.688X function as independent elements that 
facilitate X-identification and dosage compensation. While the MREs are present 
genome-wide, they are modestly enriched on the X chromosome. In contrast, 
1.688X are almost exclusive to the X chromosome. This combination of 
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sequences may give the X chromosome a distinct identity. One hypothesis is that 
1.688X and the siRNA pathway modulate the architecture of the X chromosome 
(MENON et. al., 2014). Interestingly, the X chromosome assumes a distinct 
nuclear domain in male fruitflies. Dosage compensated genes lie closer together 
in the interphase male nucleus as compared to females (GRIMAUD and 
BECKER, 2009). 1.688X flanking a puff at 2B have been implicated in the 
distinctive architecture of the tip of the X chromosome (BENOS et. al., 2000). 
Thus the DNA-motif based recruitment of the MSL complex by CESs and 1.688X-
enabled nuclear domain formation would act in complementary ways to ensure 
precise identification of the X chromosome. Parallel ideas have been proposed in 
mammalian dosage compensation, wherein the LINE repetitive elements and 
small RNA corresponding to them have been implicated in formation of a 
silencing domain comprised of the inactive X chromosome (CHOW et. al., 2010). 
The 1.688X repeats lend identity to the X chromosome 
 Previous studies demonstrated that ectopic expression of 1.6883F hpRNA 
increases male survival in roX1roX2 mutant flies, indicating that 1.6883F may be 
the source of the small RNA acting in dosage compensation (MENON et. al., 
2014).  Our current study complements these previous findings with a true 
functional test of the cis regulatory role of 1.6883F DNA. Significantly, this study 
was performed in flies that were completely wild type for the canonical dosage 
compensation machinery comprised of the roX genes and MSL proteins. When a 
transgene with 1.6883F is inserted on an autosome, recruitment and spreading of 
the MSL complex induces increased gene expression in the vicinity of the 
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transgene integration site. Increase in gene expression appears relatively 
insensitive to distance from the transgene up to 142 Kb, but is enhanced by 
elevated basal gene expression. This was unsurprising considering the X 
chromosome has only two roX genes and the 1.688X are non-uniformly 
distributed along its length. Moreover, the transgene bearing only 1.6883F also 
leads to a partial rescue of lethality associated with hemizygosity of the 
autosomal region. Rescue is enhanced by expression of hpRNA from 1.6883F, 
but this depends on 1.6883F inserted on the autosome. This is consistent with 
siRNA acting at cognate targets that are broadly but exclusively distributed on 
the X. Thus we have shown that the 1.6883F repeats identify the X chromosome 
and distinguish it from autosomes.  
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CHAPTER 4 AN INVESTIGATION OF THE ROLE OF THE 1.6884A REPEAT 
LOCUS IN DROSOPHILA MELANOGASTER DOSAGE COMPENSATION 
 
 The studies described in this chapter were completed with Lisa Spencer, 
an undergraduate student. This was a part of her Undergraduate Honors Project. 
INTRODUCTION 
 The discovery that the siRNA pathway modulates X-chromosome 
recognition and dosage compensation in Drosophila melanogaster was 
fascinating and led to many questions (MENON and MELLER, 2009). One of 
these was the source of the small RNA. The X chromosome of Drosophila 
melanogaster is enriched for a family of euchromatic satellite-related repeats 
called 1.688X (WARING and POLLACK, 1987; DIBARTOLOMIES et. al., 1991). 
Our lab discovered that when hairpin RNA (hpRNA) was expressed from the 
1.688X repeat at the 3F cytological position (called 1.6883F), it led to the 
production of siRNA, partially restored MSL complex localization to the X 
chromosome and partially rescued lethality in roX1roX2 mutant males (MENON 
et. al., 2014). However, expression of hpRNA from repeats at 1.6881A and 
1.6883C, which share 89% and 68% sequence identity to 1.6883F, did not rescue 
roX1roX2 mutant males. This unexpected specificity prompted us to further 
explore the roles of individual repeat clusters in dosage compensation.  
 The most similar repeat cluster to 1.6883F is 1.6884A. These two repeats 
share 94% sequence identity.  1.6884A is close to 1.6883F on the X chromosome, 
and these repeats flank roX1 (Fig.4.1, top). The sequence similarity prompted the 
idea that 1.6884A may play a redundant role with 1.6883F in generation of siRNA 
that is active in dosage compensation. The spatial proximity and flanking of roX1 
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may also reflect a shared function, such as delineation of a chromatin domain 
containing roX1. Therefore we decided to generate a simultaneous deletion of 
both repeat clusters and test the effect on dosage compensation.  
  1.6883F and 1.6884A are closely situated in the genome (~210Kb apart), 
and it would be extremely challenging to recombine two separate mutations to 
generate a double knockout. Therefore, we chose to use the CRISPR-Cas9 
system to delete 1.6884A in a fly strain that already lacks 1.6883F. This strain is yw 
roX1VM18A, which lacks part of the roX1 gene, the complete 1.6883F repeat cluster 
and part of echinus (ec), distal to 1.6883F (Fig. 4.1). The CRISPR-Cas9 system, 
although a relatively newly developed technique, has been widely used for 
targeted, efficient mutagenesis in Drosophila melanogaster (BASSETT and LIU, 
2014).  
MATERIALS AND METHODS 
Fly culture and genetics: 
 Flies were maintained at 25°C on standard cornmeal-agar fly food. The yw 
roX1VM18A mutation, a 15.4 Kb deletion that removes 1.6883F and mutates ec and 
roX1, has been previously described (DENG et. al., 2005). The X chromosome 
balancer Binsincy has been described (LINDSLEY and ZIMM, 1992), and 
information about a w+mC-marked X chromosome insertion at 4A4 (stock # 
13524) can be found at flybase.org.  
Cloning of chimeric RNA (chiRNA) constructs: 
 Oligos complimentary to the genomic sequence flanking 1.6884A were 
designed based on guidelines found at http://flycrispr.molbio.wisc.edu/ (Oligo and 
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primer sequences are presented in Table 4.1). Briefly, each oligo sequence 
selected was 19 nt long and flanked by an NGG PAM sequence. Sense and 
antisense oligos were designed with overhangs complimentary to those 
generated by the BbsI enzyme, and annealed to each other. The annealed oligos 
were ligated into the pU6-BbsI-chiRNA vector that had been digested with BbsI 
(WAKIYAMA et. al., 2005). We designed two primers, pU6_fwd and pU6_rev, 
flanking the BbsI site in pU6-BbsI-chiRNA. One of these primers and one of the 
oligos were used for colony PCR to identify positive clones. The positive colonies 
were tested for the presence of the insert by performing restriction digestions 
using BbsI. The BbsI site is destroyed during cloning, so correctly made 
constructs remained uncut by BbsI. Sequencing using PU6_fwd and PU6_rev 
was also used for confirmation (Applied Genomics Technology Center). Four 
CRISPR constructs were generated - DO1 and DO2 target sites immediately 
distal to 1.6884A, while PO1 and PO2 target sites immediately proximal to 
1.6884A. 
Injection and detection of flies having deletions: 
 Four mixtures of plasmids, each containing one proximal and one distal 
CRISPR construct; along with a Cas9 enzyme source were injected into yw 
roX1VM18A embryos by Rainbow Transgenic Flies Inc. (Camarillo, CA). Injected 
flies were mated to the Binsincy balancer; or to P{SUPor-P}KG04506, a w+mC-
marked insertion at 4A4 (stock # 13524) used to track inheritance of the mutated, 
unmarked X chromosome. F1 offspring were mated to Binsincy or P{SUPor-
P}KG04506 and stocks homozygous for a single mutated X chromosome were 
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established (Figs. 4.2 & 4.3 for mating strategy). After ~5 days, the F1 flies were 
removed from the cross and single fly PCR was performed using the primers 
DP2_fwd and PP1_rev, which flank the chiRNA target sites. In wild type flies, 
DP2_fwd and PP1_rev amplify an ~1150 bp product, which is rarely obtained due 
to its size. Successful deletion of 1.6884A is detected by the reduction in size of 
this amplicon to ~150 bp. Two additional flanking primers (DP1_fwd and 
PP2_rev) were also generated, but did not produce a consistently strong PCR 
product. The primers CT-Pep(F) and CT-Pep(R) produce a 550 bp amplicon 
used for template control PCR. All PCR reactions were run on the Bio-Rad 
S1000 thermal cycler on the program SJLONG50 (1= 95°C for 5:00; 2= 95°C for 
0:30; 3= 50°C for 0:30; 4= 72°C for 2:30; 5= GOTO 2, 28 times; 6= 72°C for 
10:00; 7= 4°C FOREVER; 8= END).  
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Fig. 4.1. Location of 1.6884A and CRISPR-Cas9 strategy used for deletion of 
1.6884A. The top panel shows the X chromosome with the centromere (black 
circle) on the right. The positions of three satellite repeats are indicated. The 
middle panel expands the 3F-4A region to illustrate the proximity of 1.6883F and 
1.6884A to one another and to roX1. The mutation roX1VM18A is deleted for 15.4 
Kb (black bar). The bottom panel expands 4A4, illustrating positions of the oligos 
used for generation of chiRNA constructs and primers used to detect deletions. 
1.6884A, in an intergenic region, is 4.5 Kb from the nearest annotated gene 
(CG43689). 
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Primer / Oligo name Sequence 
PO1_sense CTTCGATTATGCCCGAATGTTGTT 
PO1_antisense AAACAACAACATTCGGGCATAATC 
PO2_sense CTTCGGCAAAGCGGACAAACTAAT 
PO2_antisense AAACATTAGTTTGTCCGCTTTGCC 
DO1_sense CTTCGTTGGCACTCAGTTAATCTTA 
DO1_antisense AAACTAAGATTAACTGAGTGCCAAC 
DO2_sense CTTCGGAGATTTCATAGGCCAGTT 
DO2_antisense AAACAACTGGCCTATGAAATCTCC 
PU6_fwd AGGGTTCTTAAGACCATTTGCC 
PU6_rev GCACCGACTCGGTGCCAC 
DP1_fwd AAGCCAAACAGCCGGTGTGTCC 
DP2_fwd TTGAAAAAGTCTCGTAGGACGC 
PP1_rev GAGTCTCTGCATGTGGATCCG 
PP2_rev ACTGGGATTTGGGCCACCATGG 
CT-Pep(F) CATGCCATGGTCGGCCCGTCTTTCAG 
CT-Pep(R) CCGCTCGAGCGTGTGCCATCTTTCTG 
 
Table 4.1. Sequences of oligos used for generation of CRISPR chiRNA 
constructs and primers used for PCR.  
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Fig. 4.2. Mating strategy for injected males. Injected male flies (F0) produce 
offspring with potential deletions of 1.6884A on the X chromosome. F0 males 
were mated to Binsincy / P{SUPor-P}KG04506 virgins. All male offspring were 
discarded. Female offspring (F1) with the potential deletion (indicated by *) over 
either of the marked chromosomes were collected. Individual virgins were mated 
to Binsincy males, and homozygous stocks generated. After 5 days, the F1 
females were removed and subjected to single fly PCR for detection of 
mutations. 
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Fig. 4.3. Mating strategy for injected females. Injected female flies (F0) 
produce offspring with a potential deletion of 1.6884A on the X chromosome 
(indicated by *). F0 females were mated to Binsincy males. F1 X*/ Binsincy 
virgins were mated singly to Binsincy males, to enable generation of X*/ X* 
stocks. F1 X*/Y males were singly mated to Binsincy / P{SUPor-P}KG04506 
virgins, and offspring mated to produce X*/ X* stocks. After 5 days in the vial, F1 
flies were removed and subjected to single fly PCR for detection of mutations. 
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RESULTS 
 The pU6-BbsI-chiRNA vector enables generation of a chiRNA that targets 
the Cas9 nuclease enzyme to a homologous region of the genome (WAKIYAMA 
et. al., 2005). Constructs for two chiRNAs on each side of the 4A repeat cluster, 
DO1 and DO2 (Distal Oligo 1&2, distal to 1.6884A), and PO1 and PO2 (Proximal 
Oligo 1&2, proximal to 1.6884A) were made (Fig. 4.1, Table 4.1). From these we 
assembled four combinations of chiRNA constructs, (DO1+PO1, DO1+PO2, 
DO2+PO1 and DO2+PO2) which were sent for injection (Table 4.2). Our 
expectation was that simultaneous cuts on the proximal and distal sides of 
1.6884A would be repaired by Non-Homologous End Joining (NHEJ) to delete a 1 
Kb region. To screen for deletions we generated two primers, DP2_fwd on the 
distal side and PP1_rev on the proximal side of 1.6884A; such that a PCR product 
of ~1150 bp is obtained from a wild type fly squash. On deletion of 1.6884A we 
expected a PCR product of ~150 bp. Partial deletions, such as a single break 
repaired by NHEJ would yield PCR products of intermediate size. This would 
occur if only one of the chiRNAs introduced a break.  
 We observed PCR products of intermediate size with a relatively high 
frequency. 16.77% of examined F1 offspring yielded a PCR product larger than 
150 bp but smaller than 1150 bp, indicating a single cut that produced a small 
deletion (Table 4.2).  Different combinations of chiRNAs yielded these mutations 
with differing efficiencies (Table 4.2). In contrast, only a single injected fly yielded 
a PCR product of ~150 bp, indicating complete deletion of the 1.6884A repeat 
cluster (0.4% of offspring, Fig. 4.4A, Table 4.2). This was a female offspring (F9) 
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of a male (P1D2M10) injected with PO1 and DO2. Sequencing of the 150 bp 
PCR product revealed breakpoints adjacent to the chiRNA target sites (Fig. 
4.4B). The deleted female (P1D2M10-F9) was mated to Binsincy males, and the 
offspring mated with one another to generate a homozygous stock of 
roX1VM18A1.6884AΔ (Fig. 4.2).  
 When dosage compensation is perturbed, the male to female ratio is 
reduced. The survival of males with the roX1VM18A1.6884AΔ X chromosome was 
tested to determine if simultaneous deletion of 1.6883F and 1.6884A affects 
dosage compensation. The male/female ratio was 0.92, indicating no 
perturbation of dosage compensation. Next, we tested the role of the 
simultaneous deletion of 1.6883F and 1.6884A in a sensitized genetic background. 
Drosophila melanogaster females do not normally dosage compensate, but can 
be forced to do so by expression of MSL2 from the [w+hsp83-M2]6I transgene. 
This leads to reduced female survival, with a female/male ratio of 0.366. 
Mutations affecting the dosage compensation machinery are expected to 
improve the survival of these females. However, roX1VM18A1.6884AΔ; [w+hsp83-
M2]6I/+ flies display a female/male ratio of 0.207. Thus no conclusion can be 
drawn about the role 1.6884A in dosage compensation.  
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chiRNA 
construct 
pair 
Injected flies 
mated (F0) 
Number of 
offspring 
tested (F1) 
Partial 
deletions 
detected 
Complete 
deletions 
detected 
PO1+DO1 38 163 19.02% (31) - 
PO1+DO2 28 142 15.49% (22) 1.41% (2) 
PO2+DO1 11 91 23.08% (21) - 
PO2+DO2 15 99 9.09% (9) - 
Total 92 495 16.77% (83) 0.4% (2) 
 
Table 4.2. Number of flies screened and partial and complete deletions 
obtained using the various chiRNA construct combinations. Number of 
offspring with deletions is indicated in parentheses. 
 
 
 
 
 
 
 
 
 
 
 
 
		
75	
 
 
 
Fig. 4.4. Molecular characterization of 1.6884AΔ. (A) Identification of the 
1.6884A deletion using PCR. Amplification of a P1D2M10-F9 fly squash with the 
primers DP2_fwd and PP1_rev produces a product of 151 bp (right lane). (B) 
Confirmation of 1.6884AΔ by sequencing. The amplicon shown in (A) was 
sequenced (top) and aligned to the reference genome (bottom). Breakpoints are 
adjacent to DO2 and PO1 (underlined in the reference genome), the combination 
of chiRNA plasmids injected into P1D2M10.  
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DISCUSSION 
 The X chromosomes of several Drosophilid species are enriched in 
repetitive sequences (GALLACH, 2014). This has led to speculation that these 
sequences function in X-chromosome specific phenomena, such as dosage 
compensation. A previous study revealed that siRNA from 1.6883F, but not from 
the similar repeats 1.6881A and 1.6883C, was biologically active in dosage 
compensation (MENON et. al., 2014). The goal of this present study was to 
determine if the highly similar satellite repeat clusters 1.6883F and 1.6884A are 
redundant for generation of siRNA that participates in Drosophila melanogaster 
dosage compensation. We used the CRISPR/Cas9 system to generate the 
1.6884A deletion in a fly strain lacking 1.6883F. This double mutant allowed us to 
test the idea that two highly similar repeats at 3F and 4A were redundant in 
function. 
 roX1VM18A1.6884AΔ flies, deleted for both 1.6883F and 1.6884A repeat 
clusters, do not display an obvious male phenotype. Moreover, in the sensitized 
genetic background of induced dosage compensation in females, the 
roX1VM18A1.6884AΔ chromosome did not lead to increased female survival. 
However, these results do not rule out a function for the 1.6884A cluster in 
production of dosage compensation specific siRNA. Previous studies involving 
the role of the siRNA pathway were performed in a highly sensitive roX1roX2 
mutant background. To perform tests in a similar genetic background would 
involve recombining the roX1VM18A1.6884AΔ X chromosome with a roX2 mutation. 
This might enable detection of the effect of the 1.6884A cluster on dosage 
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compensation. An alternative possibility is that only the 1.6883F repeat cluster 
produces biologically active siRNA, but many 1.688X repeats are targets of this 
siRNA and serve to enhance recruitment to nearby genes. Precise deletion of 
1.6884A enables us to test ideas about how these repeats influence nearby 
genes. 
																																			
		
78	
CHAPTER 5 SUMMARY AND PERSPECTIVES 
 The unique distribution of the 1.688X satellite repeats on the X 
chromosome suggested that these repeats might act to identify X-chromatin. 
Therefore, I decided to test the function of 1.688X as cis-acting elements in an 
autosomal dosage compensation system. I discovered that, in addition to roX1-
containing transgenes, a transgene containing 1.6883F only could recruit the MSL 
complex to the autosome, leading to upregulation of genes in the vicinity and 
functional dosage compensation. Ectopic expression of hpRNA from the 1.6883F 
sequence further enhanced autosomal compensation, but only when 1.6883F was 
present in the autosomal transgene (Chapter 3). These findings strongly suggest 
that the 1.688X sequences are targets of an siRNA-dependent mechanism that 
identifies the X chromosome. The mechanism by which 1.6883F, and possibly 
other 1.688X repeats, act in dosage compensation is not known. Some 
interesting questions raised and possibilities are discussed below. 
Do other 1.688X repeat clusters recruit dosage compensation to an 
autosome? 
 The hundreds of 1.688X clusters on the X chromosome share an average 
of 73% similarity (KUHN et. al., 2012). If the mechanism by which these 
sequences act in dosage compensation involves recruitment of chromatin 
modifiers at cognate loci, then 1.688X repeats besides 1.6883F would also be 
expected to be targets of such modifiers, and to recruit dosage compensation in 
cis. 1.6881A and 1.6883C share 89% and 68% sequence identity respectively with 
1.6883F. Therefore, it would be interesting to know if they act as cis regulatory 
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sequences. The [>roX1> w+mC>1.6883F >] transgene is designed such that 
1.6883F can be easily replaced with any other candidate sequence that we wish 
to test. Transgenes bearing 1.6881A and 1.6883C could be tested to see if they 
recruit the MSL complex to the autosome or enhance the recovery of male larvae 
carrying a lethal deficiency on the homologous autosome. If recruitment of 
compensation in cis is a general property of 1.688X repeats, it would be 
interesting to test for enhancement of this effect with 1.6883F siRNA. 1.6883F is in 
very close proximity to roX1 on the X chromosome; and roX1 is responsible for 
initiation of dosage compensation as it is transcribed several hours before roX2 
(MELLER, 2003). On account of its close spatial proximity to roX1, 1.6883F may 
also be expressed very early, and this may enable generation of siRNA that 
participates in X-identification. Close spatial proximity of two important 
components of the dosage compensation machinery would enable co-operative 
function, thus forming a “Locus Control Region” for the entire X chromosome. 
Are specialized chromatin modifications observed at 1.688X? 
 The mechanism by which the siRNA pathway and 1.688X contribute to 
dosage compensation remains elusive. Components of the siRNA pathway have 
previously been implicated in targeting of chromatin modifications and 
heterochromatin formation in somatic tissues of Drosophila melanogaster 
(FAGEGALTIER et. al., 2009; CERNILOGAR et. al., 2011). It is possible that a 
similar phenomenon occurs at the dosage compensated X chromosome of male 
fruit flies, where siRNA originating from one or more 1.688X clusters maybe 
targeting chromatin modifications to cognate loci. Chromatin Immunoprecipitation 
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studies at the 1.688X repeats and surrounding loci could be used to test for 
enrichment of specific histone marks at the 1.688X compared to neighboring 
regions. Additionally, the presence of these same histone marks could be tested 
at the autosomal site of the [1.6883F] transgene. If such distinct chromatin marks 
are identified, then it will be interesting to see if knockdown of the RNAi pathway 
components, especially Ago2, disrupts these chromatin marks at the autosomal 
transgene. Identification of distinct chromatin marks will be a worthwhile path to 
follow because we hypothesize that these marks alter the properties of chromatin 
to enable the MSL complex to more easily enter or spread along the X 
chromosome. 
Is nuclear architecture involved in 1.6883F-based rescue? 
 The dosage compensated X chromosome has been postulated to form a 
male-specific conformation in the interphase nucleus, such that compensated loci 
lie closer together in interphase male nuclei (GRIMAUD and BECKER, 2009). It 
is possible that the 1.688X satellite repeats form long-range associations that 
may enable the X chromosome to form a specific conformation/nuclear domain 
(MENON and MELLER, 2015). It might be extremely productive to perform 
Chromosome Conformation Capture (3C), and look for associations between 
distant 1.688X satellite repeats. If long range interactions between 1.688X repeats 
do exist, then the rescue of dosage compensation by the autosomal [1.6883F] 
transgene could be a consequence of the autosomal region looping into or near 
the X chromosome territory via formation of long-range associations. The X 
territory is enriched for the MSL complex, which could move into nearby 
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transcribed genes, even if these genes are on an autosome. 3C studies between 
the autosomal transgene and X-linked loci could be performed to test this 
hypothesis. A parallel mechanism has been proposed in mammalian dosage 
compensation, where Long Interspersed Nuclear Elements (LINEs) and small 
RNAs originating from LINEs participate in the formation of a silent domain 
comprised of the inactive X chromosome (CHAUMEIL et. al., 2006; CHOW et. 
al., 2010). Moreover, the long, non-coding Xist RNA has been shown to spread 
on and silence the inactive X chromosome by exploiting the existing three-
dimensional conformation of the X (ENGREITZ et. al., 2013). 
Do additional trans-acting factors bind 1.688X or contribute to X-
identification?  
 If siRNA-dependent chromatin modifications at 1.688X are responsible for 
their mode of action in dosage compensation, then additional trans-acting 
proteins are very likely to be involved in the pathway. Drosophila protein 1 (D1) is 
a non-histone, chromosomal protein that binds AT-rich satellite repeats in 
Drosophila, and has been specifically shown to bind the 1.688g/cm3 family of 
repeats (LEVINGER and VARSHAVSKY, 1982). Co-incidentally, it shares 
features with the mammalian HMGA proteins that are known to induce structural 
changes in chromatin substrates (REEVES and BECKERBAUER, 2001; 
WEILER and CHATTERJEE, 2009). Another candidate protein for binding at the 
1.688X repeats is the chromodomain-containing Heterochromatin Protein 1 
(HP1), which recognizes and binds trimethylated Histone 3 Lysine 9 
(BANNISTER et. al., 2001). The finding that HP1 binding is significantly elevated 
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on the X chromosome compared to autosomes, in male but not female flies is 
provocative (DE WIT et. al., 2005). ChIP and knockdown studies could be 
performed in the future to test if these proteins are enriched at 1.688X repeats, 
and if they mediate the function of 1.688X sequences in Drosophila melanogaster 
dosage compensation.  	
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APPENDIX A CONFIRMATION OF TRANSGENE INTEGRATIONS BY IN-SITU 
HYBRIDIZATION 
 
 The transgene [roX1+1.6883F] was site-specifically integrated at three 
cytological positions – 22A3, 24A2 and 25C7 (Chapter 3). The individual 
integrations were then sequentially recombined to obtain a line with three 
integrations of the transgene. Recombinants were identified by dark red eye color 
and confirmed by in-situ hybridization. In-situ hybridization was performed to 
salivary gland polytene chromosomes from larvae homozygous for 
[roX1+1.6883F]22A3+24A2+25C7. A probe for 1.6883F was used and the protocol was 
performed as described (MENON et. al., 2014). Three signals were observed 
from the tip of chromosome 2L at the expected positions (Fig. A1), and thus I 
could confirm that I had generated a line with three integrations.  
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Fig. A1. Confirmation of a recombinant chromosome with three copies of 
the complete transgene. In-situ hybridization was performed using a probe to 
1.6883F. The black arrow marks the 2L telomere. Distinct signals corresponding 
to three transgene integration sites are observed.  
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APPENDIX B VERIFICATION OF TRANSGENE EXCISIONS BY PCR 
 FRT and LoxP sites were included on [roX1+1.6883F] to enable excision of 
roX1 and 1.6883F, by expression of FLP and Cre recombinase, respectively. Loss 
of w+mC and resultant white eye color enabled detection of excisions (Chapter 3). 
PCR was used for molecular confirmation of excision events using primers 
specific to sequences within roX1 and 1.6883F (Fig.B1 for schematic, Table B1 
for primers). A genomic template from a fly having the complete [roX1+1.6883F] 
transgene produced amplicons with all primer pairs. A primer pair specific to roX1 
did not amplify when genomic DNA from a fly with a [1.6883F] transgene was the 
template, but did amplify when the [roX1] transgene was present. Similarly, when 
a primer pair specific to 1.6883F was used for PCR, amplicons were detected 
from a fly containing the [1.6883F] transgene but were not detected when the 
[roX1] transgene was present (Fig. B2). 
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Fig. B1.  Schematic showing the SJTG clone and primers. The SJTG clone 
was used for generation of [roX1+1.6883F] transgene integrations. Primer names 
and sequences are presented in Table B1. 
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No. in 
Fig. B1 
Primer name Primer sequence 
- roX1F1264 CATACCTCTATCGGATGCATGTGGCG 
- roX11490R TACACTCGAGTCGATGCGTCGTTTATTG 
1 BPR08wh(F) TAGCTCCTGATCCTCTTG 
2 Sat_Frt_F GACTGCAGCGGCCGCTTCCGAAGTTCCTATTCTC    
4 roX1HincIIR CTCAATAGCATAAAAAATAGTTGACC 
5 Sat_LoxP_F ATCGTTCGGCCGTCGACTTAATATAACTTCGTATAATGTA 
6 attB_210R TGACCGTCGAGAACCCGCTGACG 
8 BPR26 GAGGTCTAGACCCACCAAAGAGGCTTGACAGAAGA 
9 roX1R_706 TCATATCCACTAGCATAAGGCTGGCG 
10 roX1_LoxP_F ATCGGTCGGCGGCCGCGCGCTTAATATAACTTCGTATAA
TGTA 
 
Table B1. Primers used for confirmation of Cre and FLP-based excisions 
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Fig. B2.  Verification of excisions of the [roX1+1.6883F] transgene. (A) 
Amplification can be detected from all templates in a control PCR reaction. (B) 
When primers specific to 1.6883F were used, a product cannot be detected in a 
squash from a fly that had the excised  [roX1] transgene. (C) Similarly, a squash 
from a fly with the excised [1.6883F] transgene does not amplify with primers 
specific to roX1. 
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APPENDIX C LIST OF PRIMERS FLANKING TRANSGENE INTEGRATION 
SITES ON 2L 
 
Integration 
site 
Primer 
name 
Primer sequence Proximity to 
insertion site 
VK00037 
22A3_F1 GAATATCTGTTCATTAGACTG Distal 
22A3_R1 CACCGCGCCGGGTAAAAAGCACATGGG Proximal 
Su(Hw)attP6 
24A2_L1 GGGTATTTTCGCTCTCCCAGAC 
Proximal 
24A2_L2 CCAAGCTTATATGGTCTCAGATC 
P{Cary}attP40 
25C7_F1 CGGATTTTCGACCACATCACTCC 
Distal 
25C7_F2 GTCTAGGGAACCGTTGACCTTG 
25C7_R1 GCGAGAATTCGGGGGCTTTCGGTG 
Proximal 
25C7_R2 CCAACCGGAGATTATCTCACGCAG 
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APPENDIX D GENERATION AND CHARACTERIZATION OF INTERNAL 
DEFICIENCIES ON 2L 
 
 After two initial failed attempts to generate large, lethal deficiencies on the 
tip of 2L that could be rescued by autosomal dosage compensation, I decided to 
generate smaller nested deficiencies on 2L. The expectation was that smaller 
deficiencies would be easier to obtain and maintain. Even if these are not 
completely lethal, other phenotypes, such as partial lethality or infertility, could be 
tested for rescue. Moreover, the nested internal deficiencies could be positioned 
such that they were closer to existing transgene integrations and might be 
rescued better.  
 I selected P-elements carrying an FRT site marked with w+mC at different 
positions on 2L. The matings were set up such that the FRT sites on the two P-
elements were in the proper orientation for recombination. Upon expression of 
FLP, if recombination occurred, an internal deficiency was generated and the 
w+mC was lost from both P-elements. Flies with these deletions were thus 
identified by white eyes (See Fig. D1 for schematic, Table D1 for positions of P-
elements and stock numbers). The deficiencies were recovered over a 
duplication of the 2nd chromosome, Dp(2;2)Cam1 (stock # 3392). The duplication 
spans from cytological positions 21E2 to 23D2, the region of the chromosome 
containing the expected deficiencies. Occasionally, instead of Dp(2;2)Cam1, we 
used Dp(2;Y) 22A2 (Chapter 2) to obtain males with internal 2L deficiencies over 
a second chromosome balancer such as CyO or In(2L2R)Bcg. 
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Fig. D1. Schematic showing strategy for generation of internal deficiencies 
on 2L.  Dysgenic flies were generated carrying P-elements with FRT sites on 
both 2nd chromosomes and a source of FLP on the 3rd chromosome. These were 
mated to flies with the Dp(2;2)Cam1 / CyO.  The dysgenic parent had red eyes. 
Offpsring with the expected deficiency were white-eyed and had straight wings.  
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 Several internal deficiencies were generated and named based on their 
size in Mb, for example a deficiency of 0.64 Mb was called Internal Deficiency 
0.64 (ID0.64). PCR was performed using a primer in the P-element and a primer 
in the flanking genomic DNA (Table D2 for list of primers). All white-eyed flies 
that produced an amplicon corresponding to at least one of the P-element ends 
involved in the recombination thus had the deficiency. Polytene squashes were 
used for confirmation of the deficiency. In a squash from a male third instar larva 
having ID1.07, the homolog can be seen unapired and looped out in the region of 
the deficiency (black arrow, Fig. D2). Deletions extending over more than one 
cytological division, 0.8-1.5 MB (median 1.1Mb) are generally lethal (STENBERG 
et. al., 2009). In accord with this, most of the internal deficiencies I generated 
were completely viable and could not be used (Table D1). 
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Name of 
Deficiency 
Size of 
Deficiency 
(Mb) 
Proximal end 
(Position & Stock #) 
Distal end 
(Position & Stock #) 
Lethal 
(Y / N) 
 
ID0.64 0.64 22E1 
(18037) 
22B2 
(d05547) 
No 
ID0.88 0.88 22A1 
(18673) 
21D1 
(d05169) 
No 
ID1.07 1.07 22A2 
(18757) 
21D1 
(d05169) 
No 
ID1.25 1.25 22B1 
(17972) 
21D1 
(d05169) 
No 
ID1.27 1.27 22B2 
(18871) 
21D1 
(d05169) 
No 
ID1.39 1.39 23D2 
(18639) 
22B2 
(d05547) 
Yes 
ID1.4 1.4 24F4 
(19264) 
23C4 
(18110) 
No 
ID1.59 1.59 23E4 
(18643) 
22B2 
(d05547) 
Yes 
ID1.63 1.63 23F1 
(18957) 
22B2 
(d05547) 
Yes 
 
Table D1.  List of internal deficiencies generated on chromosome 2L. The 
size of the deficiency is indicated in Mb, and the stock numbers are shown in 
parentheses. Only three deficiencies (all >1.3 Mb) were lethal. 
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Position of 
P-element 
Stock 
number 
Primer name Primer sequence 
21D1 d05169 21D1_dist1 CCCTCCTAGGACACGGGT 
21D1_dist2 GGGAGCATTGCCAGGCCCAAG 
22B2 d05547 22B2_dist1 CAACTTGCTACTTGACTCGAC 
22B2_dist2 CCACGCAACGATCGTTAGCG 
22E1 18037 22E1_prox1 CGCCATTTGGAACCGTACAAG 
22E1_prox2 GTACTACCCGGCTTATTTAACC 
23C4 18110 18110_F1 TTCAGAAGAACGTGAGTCGGGTATCAC 
18110_F2 GTACAACCACTGGATAACCTAATTTCGGC 
23D2 18639 23D2_prox1 CGCCGATGAACCCATTCCAAAG 
23D2_prox2 GGCTTCAGAAGTCCCTTGG 
23E4 18643 23E4_prox1 CCGCCAAGTAGGTGGTCACAC 
23E4_prox2 GCATGAGTATCCTCCTTCCGTAC 
24F4 19264 19264_R1  CATCTTTGGGCGCGGGGTCCAC 
19264_R2  CAGTTTCTCTCTGTGTATAGTTAGGGCC 
 
Table D2. List of primers used in molecular characterization of internal 
deficiencies. 
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Fig. D2. Cytological characterization of ID1.07. ID1.07 is an internal deficiency 
spanning from 21D1 to 22A2. The black arrow shows 2L, where a break can be 
seen on one homolog and the other homolog is unpaired and looped out.  
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 While ID1.63 is a lethal deficiency, I did obtain a few heterozygous 
escaper males. On mating these escapers to virgins, no embryos were observed 
in the vial, thus indicating that the males were infertile. Upon closer examination, 
I noticed genital malformations in these males (Fig. D3, panel A). I set up crosses 
to recover males with ID1.63 over a homolog carrying three integrations of the 
complete transgene [roX1+1.6883F]22A3+24A2+25C7, to see if male survival or the 
infertility phenotype could be rescued. The number of males obtained from this 
mating was similar to the number obtained with ID1.63 over a wild type homolog. 
However, ID1.63 / [roX1+1.6883F]22A3+24A2+25C7 males were fertile. Thus the 
infertility phenotype of ID1.63 / + was rescued by the transgenes (Table D3). 
Moreover, ID1.63 / [roX1+1.6883F]22A3+24A2+25C7 males also had genitalia that 
appeared normal (Fig. D3, panel B). This finding was very exciting, and I setup 
several more matings with full and reduced transgenes, and with other 
deficiencies of a similar size such as ID1.39 and ID1.63. However, I did not 
recover a significant number of offspring, and these results could not be 
replicated.  
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Fig. D3. Genital malformation is rescued by [roX1+1.6883F] transgenes. (A) 
An ID1.63 / + male shows genital malformations in the form of reduced terminal 
structures (B) An ID1.63 / [roX1+1.6883F]22A3+24A2+25C7 male shows a wild type 
rear end (C) A wild type male is pictured for reference.  
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Transgene tested Total number of 
males recovered (with 
and without ID1.63) 
% Total 
males with 
ID1.63 
% fertile 
males with 
ID1.63 
None 394 1.5 (6) 0 (6) 
[roX1+1.6883F]22A3+24A2+25C7 220 1.4 (3) 100 (3) 
 
Table D3. Number of males recovered with ID1.63. Percentage of males with 
ID1.63 is calculated as (males with ID1.63 / total number of males recovered)* 
100. Percentage of fertile males with ID1.63 is calculated as (fertile males with 
ID1.63 / total males with ID1.63)*100. Number of males is indicated in 
parentheses in each case. 
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APPENDIX E GENERATION OF LEXA OPERATOR ARRAYS 
 
Introduction  
 The dosage compensated X chromosome forms a distinct three-
dimensional domain in the interphase nucleus (GRIMAUD and BECKER, 2009). I 
wanted to test if roX1 or 1.6883F or both participate in the formation of this 
domain. To do this, I decided to label the autosomal transgene with RFP (Red 
Fluorescent Protein), and the X chromosome with GFP (Green Fluorescent 
Protein), and then determine if the autosomal region containing the transgene is 
recruited into or close to the X-specific nuclear domain by observing relative 
localization of the green and red fluorescent spots. LexA is a bacterial DNA-
binding protein that specifically recognizes and binds the LexA Operator 
(LexAop) DNA sequence element (BRENT and PTASHNE 1984). I decided to 
clone arrays of the LexAop sequence into the autosomal [roX1+1.6883F] 
transgene, and generate flies carrying a LexA-RFP transgene, such that we 
would be able to track the position of [roX1+1.6883F] in the interphase nucleus by 
RFP localization. 
Cloning of the LexAop arrays 
 The pSH18-34 vector that has 4 copies of the LexA operator, i.e. 8 binding 
sites for the LexA protein (ESTOJAK et.al., 1995) was obtained from the 
laboratory of Dr. Russell L. Finley, Jr. A SalI site present in the LexAop arrays in 
pSH18-34 was destroyed by digestion with SalI, followed by a fill-in reaction 
using T4 DNA Polymersae (NEB) and blunt end ligation. LexAop was amplified 
from this modified pSH18-34 plasmid using the primers LexOp_F and LexOp_R, 
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which contained XmaI sites (refer Table E1 for list of primers). The PCR product 
was cloned into the pCR4-TOPO vector (Invitrogen). A linker (made by annealing 
Amplink_top and Amplink_bot) was introduced into NotI and KpnI sites of 
pBlueScript-SK vector such that it now had restriction sites in the following order: 
SalI, XmaI, XhoI and BamHI. The LexAop unit was then excised from pCR4-
TOPO with XmaI and cloned into the XmaI site of the modified pBlueScript. This 
plasmid was pBS-LexAop(1). T7 and T3 primers were used to identify inserts by 
colony PCR. Restriction digestion and sequencing were used for confirmation.  
 pBS-LexAop(1) was then used in successive cycles of amplification by 
restriction digestion with XhoI and BamHI to generate the vector that contains the 
LexAop. pBS-LexAop(1) was also cut with SalI and BamHI to release the insert. 
The SalI-BamHI insert was then ligated into the XhoI-BamHI cut vector (protocol 
modified from ROBINETT et. al., 1996; see Fig. E1). Colony PCR was performed 
after each step using T7 and T3 to identify clones that had arrays of a larger size. 
Restriction mapping was used for confirmation. After 5 cycles of amplification, the 
clone pBS-LexAop(5) with LexAop arrays of ~1600 bp was produced. 
 Expanding the arrays after this step proved extremely challenging. I 
switched to CopyCutter™ EPI400™ Electrocompetent E. coli cells (Epicentre, 
Illumina) to maintain clones at low-copy number. At this step, I switched to the 
PCR program SJLONG50 for screening larger PCR products (parameters 
described in chapter 4). This enabled generation of pBS-LexAop(6), with ~2100 
bp of LexAop sequence. Although amplification was expected to be over 3 Kbp, 
the size of arrays in pBS-LexAop(6) was much smaller than what was expected 
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from a doubling of the array. This indicated that the repetitive sequence was 
unstable. 
 As the array in pBS-LexAop(6) was of a sufficient size to enable 
visualization with LexA-RFP, I decided to clone it into pUASTB. I digested pBS-
LexAop(6) using Sal, ligated it into pUASTB opened at XhoI and tried to 
transform it into the CopyCutter™ EPI400™ cells. This cloning was attempted 
several times, but was not successful.  
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Fig. E1. Schematic for amplification of LexAop arrays. pBS-LexAoP(1) was 
used in successive steps of restriction digestion and ligation to generate an array 
of LexA operators. This strategy makes use of compatible cohesive ends 
between SalI and XhoI and was modified from (ROBINETT et.al, 1996). pBS-
LexAoP(1) digested with XhoI+BamHI served as the vector. The same plasmid 
digested with SalI+BamHI, generated the insert. During ligation, the compatible 
cohesive ends of SalI and XhoI are ligated, destroying these sites and generating 
pBS-LexAop(2), with 2 copies of the basic unit. This clone was then used for the 
next amplification step, and the cycle was repeated. With each step in the 
process, the amplification is expected to be exponential.  
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Primer name Primer sequence 
LexOp_F TCTCCCGGGCCATATCTAATCTTACCTCGAC 
LexOp_R GTCGAGGGATGATAATGCGCCCGGGCTC 
Amplink_top GGCCGCGTCGACCCGGGCTCGAGGATCGAGGATCCGTAC 
Amplink_bot GGATCCTCGATCCTCGAGCCCGGGTCGACGC 
T7 TAATACGACTCACTATAGGG 
T3 ATTAACCCTCACTAAAGGGA 
 
Table E1. Primers used in cloning of LexAop arrays. 
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APPENDIX F GENERATION OF TRANSGENIC FLIES HAVING A LEXA-RFP 
TRANSGENE 
  
 In order to label an array of LexA operator sites with RFP (Appendix E), I 
needed to generate transgenic flies that express a LexA- RFP fusion protein. 
Genomic DNA from flies containing the RFP gene was used as a template to 
amplify the RFP fragment with the primers RFP_F and RFP_R. These primers 
introduce XhoI and XbaI sites, respectively (Table F1 for primer sequences). The 
PCR product (~800 bp) was cloned into the pCR4-TOPO vector (Invitrogen), to 
generate RFP-Topo. The LexA sequence (~700 bp) was amplified from the 
plasmid pNLex-NLS using the primers LexA_NLS_F and LexA_NLS_R. The 
primers introduce EcoRI and XhoI sites, respectively. A Nuclear Localization 
Signal (NLS) is included in the amplicon. This was also cloned into pCR4-TOPO 
to generate LexA-Topo. EcoRI and XhoI were used to excise the LexA-NLS 
fragment, which was cloned into pUAST (BRAND and PERRIMON, 1993) to 
generate pUAST_LexA. XhoI and XbaI were then used to excise RFP from RFP-
Topo, and the fragment was cloned into the pUAST_LexA vector to generate 
pLexA+RFP. The primers pUAST_Hsp70Prom and pUAST_SV40Ter in the 
pUAST vector flanking the MCS were used for screening clones by colony PCR. 
Restriction digestion and sequencing were used for confirmation. pLexA+RFP 
was injected into yw flies by Rainbow Transgenic Flies Inc. (Camarillo, CA). The 
injected flies were screened by eye color and homozygous stocks were set up 
(Table F2 for list of stocks). 
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Primer name Primer sequence 
RFP_F CCGCTCGAGGTCGCCACCATGAGGTCTTCC 
RFP_R GCCTCTAGAGAATTCGATGGCCGCTAAAGG 
LexA_NLS_F GCCGAATTCGCATACAATCAACTCCAAGCTTG 
LEXA_NLS_R GGACTCGAGGATCCCCGGGAATTCCAC 
pUAST_ Hsp70Prom AATCTGCAGTAAAGTGCAAG 
PUAST_ SV40Ter TAAAGGCATTCCACCACTGC 
 
Table F1. List of primers used in generation of a LexA-RFP transgene. 
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Name of stock Chromosome 
P{LexA-RFP w+} 19A2 X 
P{LexA-RFP w+} 19A5 X 
P{LexA-RFP w+} 59C X 
P{LexA-RFP w+} 59D X 
P{LexA-RFP w+} 86A X 
P{LexA-RFP w+} 9B 2 
P{LexA-RFP w+} 23A 2 
P{LexA-RFP w+} 27A 2 
P{LexA-RFP w+} 27B 2 
P{LexA-RFP w+} 56A 2 
P{LexA-RFP w+} 13D 3 
P{LexA-RFP w+} 19B 3 
P{LexA-RFP w+} 22C 3 
P{LexA-RFP w+} 23B 3 
P{LexA-RFP w+} 91D 3 
 
Table F2. List of transgenic fly stocks having a LexA-RFP transgene on the 
indicated chromosome. 
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ABSTRACT 
A NOVEL ROLE FOR REPETITIVE SEQUENCES IN RECOGNITION OF THE 
DROSOPHILA MELANOGASTER X CHROMOSOME 
 
by 
 
SONAL SURESH JOSHI 
August 2016 
Advisor: Dr. Victoria H. Meller 
Major: Biological Sciences 
Degree: Doctor of Philosophy 
 In humans and fruit flies, males have one X chromosome while females 
have two. This imbalance in gene dosage is potentially lethal, and the process of 
dosage compensation corrects it. The MSL (Male Specific Lethal) complex, 
which is composed of five proteins and one of two functionally redundant long 
non-coding roX (RNA on the X) RNAs, brings about dosage compensation in 
Drosophila melanogaster. In fruit fly dosage compensation, all the genes on the 
single male X chromosome are upregulated approximately twofold, via chromatin 
modifications, to equalize gene dosage with the two X chromosomes of females. 
This process calls for highly selective identification of the X chromosome in the 
nucleus. The current model for X-recognition does not explain how specific 
binding to the X-chromatin is achieved. It is known however, that the X 
chromosome assumes a distinct three-dimensional conformation in the male 
nucleus, and that the siRNA pathway aids in X-recognition.  
 We hypothesized that repetitive sequences found exclusively on the X 
chromosome, called the 1.688X repeats, could be a possible source of siRNAs 
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that play a role in specifying X identity, and thus promoting recognition by the 
MSL complex. To test this hypothesis, I designed a functional test that detects 
compensation of autosomal chromatin. This required generation of lethal 
autosomal deficiencies. These were made by recombining parts of the 2nd and Y 
chromosomes. These translocations can be separated meiotically to generate a 
duplication and a deficiency.  
 I then generated a transgene carrying roX1 and 1.6883F (one of the repeat 
clusters), and integrated it on an autosome. The transgene was designed such 
that the role of each element could be tested individually. I discovered that all 
transgenes, including 1.6883F only, recruited the MSL complex to the autosome 
and increased the expression of nearby genes. When placed opposite the lethal 
deficiency, the transgenes partially rescued male flies to the pharate stage. 
Additionally, all transgenes led to a dramatic increase in recovery of male third 
instar larvae, which was further enhanced by expression of siRNA from 1.6883F. 
My findings strongly suggest that the 1.688X repeats act in cis to facilitate X-
identification and dosage compensation. They also suggest that 1.688X repeats 
on the X are the targets of the siRNA pathway that contributes to X-recognition. 
 The close proximity and sequence similarity of the repeat clusters 1.6883F 
and 1.6884A prompted us to ask if they share a redundant function in generation 
of the siRNA that promotes X chromosome recognition. We discovered that flies 
deleted for both repeat clusters did not show an apparent defect in male survival. 
Thus the specialized role of 1.6883F, and whether it is unique from other 1.688X 
repeats, remains ambiguous.  
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